WO2019227331A1 - Method for constructing variable region sequence library, sequencing method, and kit thereof - Google Patents

Method for constructing variable region sequence library, sequencing method, and kit thereof Download PDF

Info

Publication number
WO2019227331A1
WO2019227331A1 PCT/CN2018/088989 CN2018088989W WO2019227331A1 WO 2019227331 A1 WO2019227331 A1 WO 2019227331A1 CN 2018088989 W CN2018088989 W CN 2018088989W WO 2019227331 A1 WO2019227331 A1 WO 2019227331A1
Authority
WO
WIPO (PCT)
Prior art keywords
sequence
variable region
primer
constructing
linker
Prior art date
Application number
PCT/CN2018/088989
Other languages
French (fr)
Chinese (zh)
Inventor
许林浩
黄智敏
Original Assignee
广州合谐医疗科技有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 广州合谐医疗科技有限公司 filed Critical 广州合谐医疗科技有限公司
Priority to PCT/CN2018/088989 priority Critical patent/WO2019227331A1/en
Priority to CN201880000622.0A priority patent/CN109415768B/en
Publication of WO2019227331A1 publication Critical patent/WO2019227331A1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing

Definitions

  • the invention belongs to the field of biotechnology, and particularly relates to a method for constructing a variable region sequence library, a sequencing method, and a kit thereof.
  • T cells T cells, B cells, macrophages, and dendritic cells. These specialized immune cells have unique structures and functions, and contain unique immune cell subgroups and functional molecules.
  • T cells and B cells are the main lymphocytes of the human body, responsible for cellular immunity and humoral immunity, respectively. Understanding the composition of T cells and B cells is helpful to the understanding, prevention and treatment of diseases.
  • T cell receptor (TCR) and B cell receptor (BCR) are composed of multiple peptide chains with antigen binding specificity.
  • the amino acid composition and arrangement order of the complementary determining region (also known as the hypervariable region) of each peptide chain It presents a high degree of diversity and constitutes a large capacity TCR library and BCR library. Studies have shown that the more subtypes, the more effective it is against pathogens such as bacteria and viruses, and the less subtypes are more likely to infect diseases. In addition, age, environment, disease-causing factors, and medication also affect the diversity of immune cells.
  • Immune Repertoire sequencing (IR-SEQ) technology came into being: it was used to amplify CDR regions for the purpose of multiplex PCR or 5'RACE technology, combined with high-throughput sequencing, from DNA or RNA The level specifically studies the immune diversity of the complementary determining regions of TCR and BCR, and is used to further explore the association between immune repertoire and disease.
  • the immune diversity detection of TCR and BCR complementarity determining regions is performed at the DNA level.
  • the V genes and J gene fragments that make up the CDR regions of TCR and BCR are used to design primers, and the CDR regions are amplified.
  • the amplified products were spliced, and the TCR and BCR diversity were detected in next-generation sequencing.
  • Another part of the research is to detect the immune diversity of TCR and BCR complementarity determining regions at the RNA level.
  • the main use is the reverse transcription reaction of the terminal C region of the CDR regions of TCR and BCR, which extends to the V region of the CDR region, and then performs the product.
  • Amplification and second-generation sequencing were performed to analyze the TCR and BCR diversity.
  • the existing technologies for detecting TCR and BCR diversity still have the following problems.
  • the main problems are, first, the V at both ends of the CDR region. J is very diverse, and the primer set required at each end may range from several primers to dozens of primers, depending on the design of the primers.
  • the set of primer pairs is used for amplification. Because there are many primer sets at both ends, primer mismatch on the template is easy to occur, and the amplification efficiency is relatively low. Once the main amplicon is formed, it is easy to cause amplification bias.
  • RNA for reverse transcription PCR to amplify the CDR regions of TCR and BCR also has some problems.
  • the processing of RNA samples is more difficult than that of DNA samples, and it is unstable and prone to degradation. At this stage, it is easier to lose diversity information.
  • some current reverse transcription schemes require adaptor conversion in the last step of the extension, but the conversion rate of the existing adaptor conversion technology is low. If the adaptor conversion cannot be successfully performed, in the subsequent steps, this part Information loss also has a large bias for diversity results.
  • each T cell or B cell corresponds to a unique TCR or BCR
  • the RNA sample may be transcribed in a large amount of cells, it is impossible to achieve that each T cell or B cell corresponds to a unique TCR or BCR. Correspondence.
  • the present invention discloses a method for constructing a variable region sequence library, a sequencing method, and a kit thereof, which can effectively solve the low amplification efficiency and bias of amplification existing in the current technology for constructing variable region sequence libraries of TCR or BCR And the technical defects that easily lose the sequence information of the variable region sequence library.
  • the invention provides a method for constructing a variable region sequence library and a method for sequencing a variable region sequence, including the following steps:
  • Step 1 Obtain a DNA sample containing a variable region
  • Step 2 Use the DNA sample as a template to extend a DNA sequence encoding the variable region through a first primer group to obtain a first amplification product library, wherein the first primer group includes a specific recognition region for the J region.
  • First primers of all subtype coding sequences, the first primers include a nucleotide sequence that specifically recognizes the coding sequence of the J region, a proofreading random segment, and a first linker, and the code that specifically recognizes the J region
  • the nucleotide sequence of the sequence, the proofreading random segment and the first linker are sequentially connected, and the sequences of the proofreading random segment of the first primer group are different from each other;
  • Step 3 Using the first amplification product library as a template, a DNA sequence encoding the variable region is amplified by primers of a second primer group and a first adapter to obtain a variable region sequence combination product, wherein the The second primer group includes a second primer that specifically recognizes coding sequences of all subtypes of the V region; the second primer includes a nucleotide sequence and a second linker that specifically recognizes coding sequences of the V region, and the The nucleotide sequence that specifically recognizes the coding sequence of the V region and the second linker are connected to each other; the primers of the first linker include a nucleotide sequence that specifically recognizes the first linker.
  • the first primer group includes a plurality of first primers with different sequences, and the sequence of the proofreading random segment of each of the first primers is different from each other, and each of the first primers includes a specific recognition region of the J region.
  • the first primer group includes a sequence that specifically recognizes all subtypes of the J region.
  • the first primer A includes a sequence that specifically recognizes a subtype of the J region A subtype.
  • Primer B includes a sequence that specifically recognizes the coding sequence of the J region B subtype, and so on.
  • the first primer group includes primers of the first primer A, the first primer B, and the like; and the second primer group includes multiple sequences.
  • Different second primers each of which includes a sequence that specifically recognizes one subtype of the V region, and the second primer group includes a sequence that specifically recognizes all subtypes of the V region, such as
  • the second primer A includes a sequence that specifically recognizes the coding region of the V region A subtype
  • the second primer B includes the sequence that specifically recognizes the coding region of the V region B subtype, and so on
  • the second primer group includes the second primer A, second primer B, etc.
  • the first adaptor and the second adaptor are sequences used to construct a library, and the constructed library includes a sequencing library or a gene library.
  • nucleotide sequence of the coding sequence that specifically recognizes the V region and the second linker are connected to each other.
  • the coding sequence of the J region is a sequence of all subtypes of the J-fragment of the receptor-encoding gene of the B-cell receptor or the T-cell receptor. Therefore, the first primer group includes a specific recognition of the B-cell receptor or the T-cell.
  • the nucleotide sequences of the coding sequences of the J regions of all the subtypes of the receptors are different because the coding sequences of the J regions of all the subtypes of the B cell receptor or the T cell receptor are different.
  • the sequences of the nucleotide sequences that specifically recognize the coding sequence of the J region are different from each other.
  • the coding sequence of the V region is the sequence of all subtypes of the V-fragment of the receptor-encoding gene of the B-cell receptor or the T-cell receptor
  • the second primer group includes a specific recognition of the B-cell receptor or the T cell
  • the nucleotide sequences of the coding regions of the V regions of all the subtypes of the receptors are different because the coding sequences of the V regions of all the subtypes of the B cell receptor or the T cell receptor are different.
  • the sequences of the nucleotide sequences that specifically recognize the coding sequence of the J region are different from each other.
  • step 4 is further included.
  • the step 4 specifically includes: using the variable region sequence combination product as a template, amplifying a DNA sequence encoding the variable region through a first sequencing adapter and a second sequencing adapter to obtain a variable Region sequence library, wherein the first sequencing linker includes a nucleotide sequence that specifically recognizes the first linker and linker A for sequencing; the second sequencing linker includes a nucleoside that specifically recognizes the second linker Acid sequence and adapter B for sequencing.
  • the purpose of step 4 is to connect the variable region sequence combination product with a sequencing adapter necessary for high-throughput sequencing.
  • the sequence length of the proofreading random segment is 8-20 nucleotides.
  • the sequence length of the proofreading random segment is 8-10 nucleotides.
  • the sequence length of the proofreading random segment is 8-10 nucleotides, which can improve the recognition efficiency of the first primer group annealing, contribute to efficient extension, and improve the yield of the product.
  • sequences of the plurality of first linkers are identical to each other.
  • the amplification of the third step is a multiplex PCR, which specifically includes: pre-denaturation 95 ° C, 15s; denaturation 94 ° C, 40s; annealing 60 ° C, 4min; extension 72 ° C, 90s; final extension 72 ° C, 10s; 35 cycles.
  • the DNA sample is used as a template, and the single primer extension technology is used to encode the DNA sequence of the variable region by the first primer extension technology to obtain the first amplification product library.
  • the single primer extension technology can effectively process the DNA sample and avoid Some of the inconveniences of RNA sample processing (the efficiency of adding adaptors during reverse transcription of RNA is very low), compared with RNA that needs to convert adaptors, the efficiency is also improved.
  • the multiplex PCR in step 3 only needs to perform multiplex PCR with the first linker primer at one end, and the efficiency of the multiplex PCR is also improved.
  • variable region sequence is a variable region sequence of a B cell receptor or a T cell receptor.
  • the DNA sample containing the variable region is whole genomic DNA extracted from animal peripheral blood.
  • the sequences of the proofreading random segments of the first primer group do not generate primer dimers with each other, thereby improving the efficiency of introducing proofreading random segments.
  • the present invention also provides a kit for constructing a variable region sequence library, which includes the following primers: a first primer group, a first linker primer, and a second primer group;
  • the first primer group includes first primers that specifically recognize coding sequences of all subtypes of the J region;
  • the first primer includes a nucleotide sequence that specifically recognizes the coding sequence of the J region, a proofreading random segment, and a first linker, and the nucleotide sequence that specifically recognizes the coding sequence of the J region, and the proofreading random segment. Connected to the first link in sequence, and the sequences of the proofreading random segments of the first primer group are different from each other;
  • the second primer group includes second primers that specifically recognize coding sequences of all subtypes of the V region;
  • the second primer includes a nucleotide sequence that specifically recognizes the coding sequence of the V region and a second linker, and the nucleotide sequence that specifically recognizes the coding sequence of the V region and the second linker are connected to each other;
  • the primer of the first linker includes a nucleotide sequence that specifically recognizes the first linker.
  • the DNA sample encoding the variable region is a sequence of a T cell receptor
  • the first primer group includes a nucleotide sequence shown in SEQ ID NO: 1-13.
  • the DNA sample encoding the variable region is a sequence of a T cell receptor
  • the second primer group includes a nucleotide sequence shown in SEQ ID NO: 14-65.
  • the DNA sample encoding the variable region is a sequence of a B-cell receptor
  • the first primer group includes a nucleotide sequence shown in SEQ ID NOs: 66-71.
  • the DNA sample encoding the variable region is a sequence of a B-cell receptor
  • the second primer group includes a nucleotide sequence shown in SEQ ID NOs: 72-85.
  • the first linker is a nucleotide sequence shown in SEQ ID NO: 86.
  • the second linker is a nucleotide sequence shown in SEQ ID NO: 87, and the sequence of SEQ ID NO: 87 is: TCGTCGGCAGCGTCAGATGTGTATAAGAGACAG.
  • the kit for constructing a variable region sequence library according to the present invention further includes a first sequencing adapter and a second sequencing adapter;
  • the first sequencing adapter includes a nucleotide sequence that specifically recognizes the first adapter and sequencing adapter A; the second sequencing adapter includes a nucleotide sequence that specifically recognizes the second adapter and sequencing Use connector B.
  • the linker A for sequencing and the linker B for sequencing are special primers of a second-generation sequencer or a third-generation sequencer.
  • the invention also provides a kit for constructing a variable region sequence library, which comprises: a primer set of SEQ ID NO: 1-SEQ ID NO: 87 and a PCR amplification reagent.
  • PCR amplification reagents include enzymes, NTPs, Buffer and buffers commonly used in PCR.
  • the invention also discloses a method for sequencing a variable region sequence, comprising the method as described above or a kit for constructing a variable region sequence library as described, and constructing a variable region sequence library; and The variable region sequencing library was subjected to high-throughput sequencing to obtain variable region sequences.
  • the high-throughput sequencing is performed using at least one selected from the group consisting of Hiseq, Miseq, 454, SOLiD, Ion Torrent, and CG sequencing platform.
  • the adaptor primer of the embodiment of the present invention is illumina Sequencing primers.
  • the proofreading random segment specifically includes a randomly synthesized DNA sequence.
  • the invention also discloses the application of a method for constructing a variable region sequence library in a method for accurately analyzing a TCR / BCR library.
  • the purpose of the present invention is to address the shortcomings of the existing technology for constructing a variable region sequence library of TCR or BCR by using DNA and RNA.
  • the disclosed method for constructing a variable region sequence library includes three steps: step one, obtaining A DNA sample containing a variable region is encoded; step two, using the DNA sample as a template, extending a DNA sequence encoding the variable region through a first primer group to obtain a first amplified product library, wherein the first The primer group includes a plurality of first primers each having a different sequence, the first primer includes a nucleotide sequence that specifically recognizes a coding sequence of the J region, a proofreading random segment, and a first linker, and the specifically recognizes the J region The nucleotide sequence of the coding sequence, the proofreading random segment and the first linker are connected in sequence.
  • the sequence of the proofreading random segment of each of the first primers is different from each other.
  • the nucleotide sequence of the coding sequence includes a sequence of a coding sequence that specifically recognizes a subtype of the J region, and the first primer group includes a sequence of a coding sequence that specifically recognizes all the subtypes of the J region; step three.
  • An amplification product library is used as a template, and a DNA sequence encoding the variable region is amplified by primers of a second primer group and a first adaptor to obtain a variable region sequence combination product, wherein the second primer group includes a plurality of A second primer having a different sequence, the second primer including a nucleotide sequence that specifically recognizes the coding sequence of the V region and a second linker, and the primer of the first linker includes a nucleoside that specifically recognizes the first linker Acid sequence, the nucleotide sequence of each coding sequence that specifically recognizes the V region includes a sequence that specifically recognizes a subtype of the V region, and the second primer group includes a sequence that specifically recognizes all subtypes The sequence of the coding sequence of the V region.
  • step two it is added to the DNA sample by extension.
  • step two high-throughput sequencing is needed to obtain the complete sequence of the variable region library.
  • multiple PCR products of the variable region sequence are combined to introduce different PCR errors, and a proofreading random segment is added to the DNA sample.
  • Each template has a unique random segment, which is a one-to-one correspondence.
  • this part of the random fragment is amplified simultaneously with the connected PCR fragment to obtain a large number of amplicons.
  • step three the DNA sequence encoding the variable region is amplified by a second primer and a primer of the first linker.
  • the primer of the first linker is a single primer
  • the second primer group includes a coding sequence that specifically recognizes the V region.
  • Nucleotide sequence and the second linker so performing a one-to-many multiplex PCR can ensure the amplification efficiency of step three and the yield of the combined product of the variable region sequences.
  • the use of a DNA sample in the present invention can realize a one-to-one correspondence between each T cell or B cell corresponding to a unique TCR or BCR, which is beneficial to comprehensively evaluate the diversity of the TCR or BCR of the body.
  • FIG. 1 shows a schematic flowchart of a method for constructing a variable region sequence library according to the present invention
  • FIG. 2 is a schematic diagram of a bias process of correcting a random segment according to the present invention
  • FIG. 3 shows the TCR unique clone number analysis of Example 1 provided by the present invention
  • Figure 4 shows the analysis of the number of unique clones of BCR in Example 1 provided by the present invention
  • First library of amplification products 5 second adapter 6, nucleotide sequence that specifically recognizes the coding sequence of the V region 7, variable region sequence combination product 8, primers for the first adapter 9, second sequencing adapter 10, Variable region sequence library 11, first sequencing adapter 12.
  • the invention provides a kit for constructing a variable region sequence library and a method for constructing a variable region sequence library, which are used to solve the low amplification efficiency, bias, and ease of amplification existing in the current technology for constructing variable region sequence libraries of TCR or BCR.
  • the present invention discloses a method for constructing a variable region sequence library, which includes the following steps:
  • Step 1 Obtain a DNA sample 1 containing a variable region encoding
  • Step two 101 Use the DNA sample 1 as a template to extend the DNA sequence encoding the variable region through a first primer group to obtain a first amplification product library 5, where the first primer group includes a plurality of different ones.
  • the first primer includes a nucleotide sequence 4 that specifically recognizes the coding sequence of the J region, a proofreading random segment 3 and a first linker 2, and a nucleotide sequence 4 that specifically recognizes the coding sequence of the J region.
  • the proofreading random segment 3 and the first adaptor 2 are connected in sequence.
  • the sequences of the proofreading random segment 3 of each first primer are different from each other.
  • the nucleotide sequence of each coding sequence that specifically recognizes the J region includes specifically identifying a subtype. Sequence of the coding sequence of the J region, the first primer group includes a sequence of coding sequences that specifically recognize all subtypes of the J region;
  • Step 3 102.
  • the DNA sequence encoding the variable region is amplified by the second primer group and the primer 9 of the first linker to obtain a variable region sequence combination product 8.
  • the second primer The group includes a plurality of second primers with different sequences.
  • the second primer includes a nucleotide sequence 7 and a second linker 6 that specifically recognize the coding sequence of the V region.
  • the primer 9 of the first linker includes the first linker that specifically recognizes the first linker.
  • each nucleotide sequence that specifically recognizes the coding sequence of the V region includes a sequence that specifically recognizes a subtype of the V region
  • the second primer group includes a sequence that specifically recognizes all subtypes The sequence of the coding sequence of the V region.
  • Step 4103 specifically includes: using the variable region sequence combination product 8 as a template, and amplifying and encoding the variable through the first sequencing adapter 12 and the second sequencing adapter adapter 10.
  • the variable region sequence library 11 is obtained, wherein the first sequencing linker includes a nucleotide sequence that specifically recognizes the first linker and the linker A for sequencing; the second sequencing linker 10 includes a linker that specifically recognizes the second linker. Nucleotide sequence and adapter B for sequencing.
  • the embodiment of the present invention provides a specific method for constructing a variable region sequence library. The steps are as follows:
  • Primer Primer has 52 TRBV, 13 TRBJ random, 14 IgHV, 6 IgHJ random, 1 overhang, all reconstituted to 100 ⁇ M as stock primer (storage primer).
  • each of the 52 TRBVs was diluted into 48 ⁇ l ddH 2 O into 48 ⁇ l ddH 2 O to prepare 100 ⁇ l TRBV working primers.
  • the second primer was the TRBV working primer.
  • the second primer included SEQ ID NO: 14-65. Display nucleotide sequence;
  • TRBJ random samples were each diluted with 3 ⁇ l to 11 ⁇ l ddH 2 O, and were prepared into 50 ⁇ l TRBJ random working primers, in which random is a proofreading random segment, and the number of random fragments is 18 nucleotides.
  • a primer group is a working primer of TRBJ random, and a working primer of TRBJ random includes a nucleotide sequence shown in SEQ ID NOs: 1-13;
  • IgHV samples were each diluted to 36 ⁇ l ddH 2 O to prepare 50 ⁇ l IgHV working primers.
  • the second primer was the IgHV working primer.
  • the IgHV working primers are shown in SEQ ID NOs: 72-85. Nucleotide sequence
  • IgHJ random samples were each diluted with 3 ⁇ l to 32 ul ddH 2 O, and 50 ⁇ l IghJ random working primers were prepared, in which random is a proofreading random segment, and the number of random fragments is 18 nucleotides.
  • a primer group is an IghJ random working primer, and the IghJ random working primer includes a nucleotide sequence shown in SEQ ID NOs: 66-71;
  • Overhang made a 10 ⁇ dilution (10 ⁇ M) to prepare 50 ⁇ l of the overhang working primer.
  • the first linker was Overhang, the first linker was the nucleotide sequence shown in SEQ ID NO: 86, and the second linker. It is the nucleotide sequence shown in SEQ ID NO: 87.
  • TRB is a heavy chain of the T cell receptor, and this partial sequence contains a CDR3 region that determines the diversity of the T cell receptor.
  • IgH is the heavy chain of B-cell receptors, and this partial sequence contains CDR3 regions that determine the diversity of B-cell receptors.
  • AMPure XP should be warmed to room temperature before use and divided into tubes for use; 80% alcohol by volume should be prepared freshly; Purify uses 1.5ml centrifuge tubes or 96-well plates with 200 ⁇ l or more.
  • step 3.6 Repeat step 3.6 once (there are two 80% ethanol washings);
  • AMPure XP should be warmed to room temperature before use and divided into tubes for use; 80% alcohol by volume should be prepared freshly; Purify uses 1.5ml centrifuge tubes or 96-well plates with 200 ⁇ l or more.
  • step 3.10 Repeat step 3.10 once (there are two washings with a volume concentration of 80% ethanol).
  • sequencing primer 1 includes a nucleotide sequence that specifically recognizes the first linker (SEQ ID NO: 86) and sequencing linker A; sequencing primer 2 includes a nucleotide sequence that specifically recognizes the second linker (SEQ ID NO: 87) and Sequencing adapter B, Sequencing adapter A and Sequencing adapter B are primers for illumina sequencer.
  • AMPure XP is warmed to room temperature before use, and aliquoted into a centrifuge tube; 80% alcohol by volume must be freshly prepared; Purify uses a 1.5ml centrifuge tube or a 96-well plate with 200 ⁇ l or more.
  • step 3.6 Repeat step 3.6 once (there are two washings with a volume concentration of 80% ethanol).
  • the primers of the comparative example had 52 TRBV, 13 TRBJ, 14 IgHV, 6 IgHJ, all of which were reconstituted to 100 ⁇ M as stock primer (storage primer).
  • 52 TRBVs were each diluted by 1 ⁇ l into 48 ⁇ l ddH 2 O to prepare 100 ⁇ l TRBV working primers; as shown in Table 6, 13 TRBJs were each diluted by 3 ⁇ l and diluted to 11 ⁇ l ddH 2 O, and prepared into 50 ⁇ l.
  • TRBJ working primers as shown in Table 3, 14 IgHVs were each diluted to 36 ⁇ l ddH 2 O to prepare 50 ⁇ l IgHV working primers; as shown in Table 7, 6 IgHJs were each diluted to 3 ⁇ l to 32 ⁇ l ddH 2 O , Formulated into 50 ⁇ l IghJ working primer.
  • TRBJ working primers 2.5 100ng DNA + ddH 2 O 17.5 ⁇ l Total 50 ⁇ l
  • AMPure XP is warmed to room temperature before use, and aliquoted into a centrifuge tube; 80% alcohol by volume must be freshly prepared; Purify uses a 1.5ml centrifuge tube or a 96-well plate with 200 ⁇ l or more.
  • step 3.10 Repeat step 3.10 once (there are two washings with a volume concentration of 80% ethanol).
  • sequencing primer 1 includes a nucleotide sequence that specifically recognizes the first linker (SEQ ID NO: 86) and sequencing linker A; sequencing primer 3 includes a nucleotide sequence that specifically recognizes GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAG and sequencing linker B, sequencing The adaptor A and the adaptor B for sequencing are primers for the illumina sequencer.
  • AMPure XP is warmed to room temperature before use, and aliquoted into a centrifuge tube; 80% alcohol by volume must be freshly prepared; Purify uses a 1.5ml centrifuge tube or a 96-well plate with 200 ⁇ l or more.
  • Example 1 adds a proofreading random segment to the variable region library, which is beneficial for sequencing analysis.
  • the coefficient of variation of the number of TCR clones in the comparative example is 24.8%, and the coefficient of variation of the number of TCR clones in Example 1 is 3.9%, which illustrates the results produced by the scheme of Example 1. It is relatively stable.
  • the average number of TCR clones in the comparative example is 46,906 unique clones, and the average number of TCR clones in Example 1 is 65,741 unique clones, indicating that the unique clones generated in Example 1 are more abundant.
  • the results produced by the comparative example scheme fluctuated greatly, and the number of unique clones produced at the same time was relatively small.
  • the 2M sequencing Reads on the left side of the abscissa of FIG. 4 is the data of the number of BCR clones performed after the comparative library is built
  • the 2M sequencing Reads + random barcode on the right is the BCR clone of the library built in the IgH VJ area of Example 1.
  • the coefficient of variation shown in Figure 4 the coefficient of variation of the number of BCR clones in the comparative example is 32.7%, and the coefficient of variation of the number of BCR clones in Example 1 is 3.7%, indicating that the results produced by the solution of Example 1 are relatively stable.
  • the average number of BCR clones in the comparative example is 55,861 unique clones, and the number of BCR clones in Example 1 is 76,370 unique clones, indicating that the unique clones generated in Example 1 are more abundant.
  • the results produced by the comparative example scheme have relatively large fluctuations and relatively few unique clones.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Provided is a method for constructing a variable region sequence library, comprising: (1) obtaining a DNA sample comprising an encoding variable region; (2) using the DNA sample as a template, and amplifying and encoding a DNA sequence of the variable region by using a first primer group to obtain a first amplification product library; and (3) using the first amplification product library as a template, and amplifying and encoding the DNA sequence of the variable region by using a second primer group and a primer of a first joint, thus obtaining a variable region sequence combination product. Further provided are a kit for constructing the variable region sequence library, and a sequencing method for a variable region sequence.

Description

可变区序列文库构建方法、测序方法及其试剂盒Variable region sequence library construction method, sequencing method and kit 技术领域Technical field
本发明属于生物技术领域,尤其涉及可变区序列文库构建方法、测序方法及其试剂盒。The invention belongs to the field of biotechnology, and particularly relates to a method for constructing a variable region sequence library, a sequencing method, and a kit thereof.
背景技术Background technique
“免疫”是人体极其重要的自卫功能,依靠自身的免疫力,能抵御种类庞大的各种疾病,几乎人体内所有的疾病都与免疫息息相关。人体微环境内负责保卫机体的免疫细胞主要有T细胞、B细胞、巨噬细胞、树突细胞等,这些专职免疫细胞具有独特的结构和功能,并含有独特的免疫细胞亚群和功能分子。T细胞和B细胞是人体主要的淋巴细胞,分别负责细胞免疫和体液免疫,深入了解T细胞和B细胞的组成有助于对疾病的理解、预防与治疗。T细胞受体(TCR)和B细胞受体(BCR)是由多条肽链组成,具有抗原结合特异性,每条肽链的互补决定区(又称超变区)的氨基酸组成和排列顺序呈现高度多样性,构成容量巨大的TCR库和BCR库,研究表明亚型越多,越能有效抵抗细菌、病毒等病原体侵袭,亚型越少越容易感染疾病。另外年龄、环境、疾病诱发因素以及用药等也影响着免疫细胞的多样性。由此,免疫组库测序(Immune Repertoire sequencing,简称为IR-SEQ)技术应运而生:它是以多重PCR或5'RACE技术目的扩增CDR区,在结合高通量测序,从DNA或者RNA水平专门研究TCR和BCR的互补决定区的免疫多样性,用于深入挖掘免疫组库与疾病的关联。"Immunity" is an extremely important self-defense function of the human body. Depending on its own immunity, it can resist a large variety of diseases. Almost all diseases in the human body are closely related to immunity. The immune cells responsible for defending the body in the human microenvironment are mainly T cells, B cells, macrophages, and dendritic cells. These specialized immune cells have unique structures and functions, and contain unique immune cell subgroups and functional molecules. T cells and B cells are the main lymphocytes of the human body, responsible for cellular immunity and humoral immunity, respectively. Understanding the composition of T cells and B cells is helpful to the understanding, prevention and treatment of diseases. T cell receptor (TCR) and B cell receptor (BCR) are composed of multiple peptide chains with antigen binding specificity. The amino acid composition and arrangement order of the complementary determining region (also known as the hypervariable region) of each peptide chain It presents a high degree of diversity and constitutes a large capacity TCR library and BCR library. Studies have shown that the more subtypes, the more effective it is against pathogens such as bacteria and viruses, and the less subtypes are more likely to infect diseases. In addition, age, environment, disease-causing factors, and medication also affect the diversity of immune cells. As a result, Immune Repertoire sequencing (IR-SEQ) technology came into being: it was used to amplify CDR regions for the purpose of multiplex PCR or 5'RACE technology, combined with high-throughput sequencing, from DNA or RNA The level specifically studies the immune diversity of the complementary determining regions of TCR and BCR, and is used to further explore the association between immune repertoire and disease.
目前从DNA水平进行TCR、BCR互补决定区的免疫多样性检测,主要是利用组成TCR、BCR的CDR区的V基因以及J基因片段进行引物的设计,进行CDR区的扩增,然后这部分扩增产物进行加接头,在二代测序进行TCR和BCR多样性的检测。另外一部分研究是从RNA水平进行TCR、BCR互补决定区的免疫多样性检测,主要是利用TCR、BCR的CDR区的末端C区进行逆转录反应,延伸至CDR区的V区端,然后进行产物的扩增,并进行二代测序,分析TCR、BCR多样性。At present, the immune diversity detection of TCR and BCR complementarity determining regions is performed at the DNA level. Primarily, the V genes and J gene fragments that make up the CDR regions of TCR and BCR are used to design primers, and the CDR regions are amplified. The amplified products were spliced, and the TCR and BCR diversity were detected in next-generation sequencing. Another part of the research is to detect the immune diversity of TCR and BCR complementarity determining regions at the RNA level. The main use is the reverse transcription reaction of the terminal C region of the CDR regions of TCR and BCR, which extends to the V region of the CDR region, and then performs the product. Amplification and second-generation sequencing were performed to analyze the TCR and BCR diversity.
然而,现有的TCR和BCR多样性的检测的技术仍存在以下问题,首 先,利用DNA进行多重PCR对TCR、BCR的CDR区进行扩增,主要存在的问题有,首先是CDR区两端的V,J非常多样,可能每端需要的引物组为几个引物到几十个引物,取决于引物的设计。成套的引物对进行扩增,因为两端的引物组引物多,容易发生模板上引物不匹配,扩增效率相对较低,而一旦形成了主要的扩增子,则容易引起扩增偏倚性。另外一方面,由于二代测序本身的属性,容易在测序过程中引入错误,而目前的多重PCR方案并不能进行校正分析,对于多样性的检测往往带来很大的偏差。其次,利用RNA进行逆转录PCR对TCR、BCR的CDR区进行扩增也同时存在着一些问题,RNA样本的处理难度相比DNA的样本更加的困难,且不稳定,容易发生降解,在样本处理这一环节,已经是更加的容易丢失多样性信息。同时,目前有些方案的逆转录方案需要在延伸最后一个环节进行接头转换,但是现有的接头转换的转换技术的转换率较低,如果不能成功进行接头转换,则在后续的环节中,该部分信息丢失,同样对于多样性结果有较大的偏差。此外,因为每一个T细胞或者B细胞对应一个特有的TCR或者BCR,而RNA样本有可能在一个细胞中进行了大量的转录,无法实现每一个T细胞或者B细胞对应一个特有的TCR或者BCR的对应关系。However, the existing technologies for detecting TCR and BCR diversity still have the following problems. First, using DNA to perform multiplex PCR to amplify the CDR regions of TCR and BCR. The main problems are, first, the V at both ends of the CDR region. J is very diverse, and the primer set required at each end may range from several primers to dozens of primers, depending on the design of the primers. The set of primer pairs is used for amplification. Because there are many primer sets at both ends, primer mismatch on the template is easy to occur, and the amplification efficiency is relatively low. Once the main amplicon is formed, it is easy to cause amplification bias. On the other hand, due to the nature of second-generation sequencing, it is easy to introduce errors in the sequencing process, and the current multiplex PCR scheme cannot perform correction analysis, which often brings great deviations to the detection of diversity. Second, the use of RNA for reverse transcription PCR to amplify the CDR regions of TCR and BCR also has some problems. The processing of RNA samples is more difficult than that of DNA samples, and it is unstable and prone to degradation. At this stage, it is easier to lose diversity information. At the same time, some current reverse transcription schemes require adaptor conversion in the last step of the extension, but the conversion rate of the existing adaptor conversion technology is low. If the adaptor conversion cannot be successfully performed, in the subsequent steps, this part Information loss also has a large bias for diversity results. In addition, because each T cell or B cell corresponds to a unique TCR or BCR, and the RNA sample may be transcribed in a large amount of cells, it is impossible to achieve that each T cell or B cell corresponds to a unique TCR or BCR. Correspondence.
综上所述,研发一种高效扩增,无偏倚性,分析结果准确,可以全面构建TCR或者BCR的可变区序列文库的技术方案是本领域技术人员亟待解决的技术问题。In summary, it is a technical problem for those skilled in the art to develop a technical solution for efficient amplification, unbiasedness, accurate analysis results, and comprehensive construction of a variable region sequence library of TCR or BCR.
发明内容Summary of the Invention
有鉴于此,本发明公开了可变区序列文库构建方法、测序方法及其试剂盒,能有效解决目前构建TCR或者BCR的可变区序列文库技术存在的扩增效率低、扩增存在偏倚性以及容易丢失可变区序列文库序列信息的技术缺陷。In view of this, the present invention discloses a method for constructing a variable region sequence library, a sequencing method, and a kit thereof, which can effectively solve the low amplification efficiency and bias of amplification existing in the current technology for constructing variable region sequence libraries of TCR or BCR And the technical defects that easily lose the sequence information of the variable region sequence library.
本发明提供了可变区序列文库的构建方法和可变区序列的测序方法,包括以下步骤:The invention provides a method for constructing a variable region sequence library and a method for sequencing a variable region sequence, including the following steps:
步骤一、获得含有编码可变区的DNA样本;Step 1: Obtain a DNA sample containing a variable region;
步骤二、以所述DNA样本作为模板,通过第一引物群延伸编码所述 可变区的DNA序列,获得第一扩增产物库,其中,所述第一引物群包括特异性识别J区的所有亚型的编码序列的的第一引物,所述第一引物包括特异性识别J区的编码序列的核苷酸序列、校对随机段和第一接头,且所述特异性识别J区的编码序列的核苷酸序列、所述校对随机段和所述第一接头依次连接,所述第一引物群的校对随机段的序列互不相同;Step 2: Use the DNA sample as a template to extend a DNA sequence encoding the variable region through a first primer group to obtain a first amplification product library, wherein the first primer group includes a specific recognition region for the J region. First primers of all subtype coding sequences, the first primers include a nucleotide sequence that specifically recognizes the coding sequence of the J region, a proofreading random segment, and a first linker, and the code that specifically recognizes the J region The nucleotide sequence of the sequence, the proofreading random segment and the first linker are sequentially connected, and the sequences of the proofreading random segment of the first primer group are different from each other;
步骤三、以所述第一扩增产物库作为模板,通过第二引物群和第一接头的引物扩增编码所述可变区的DNA序列,获得可变区序列组合产物,其中,所述第二引物群包括特异性识别V区的所有亚型的编码序列的的第二引物;所述第二引物包括特异性识别V区的编码序列的核苷酸序列和第二接头,且所述特异性识别V区的编码序列的核苷酸序列和所述第二接头相互连接;所述第一接头的引物包括特异性识别第一接头的核苷酸序列。Step 3: Using the first amplification product library as a template, a DNA sequence encoding the variable region is amplified by primers of a second primer group and a first adapter to obtain a variable region sequence combination product, wherein the The second primer group includes a second primer that specifically recognizes coding sequences of all subtypes of the V region; the second primer includes a nucleotide sequence and a second linker that specifically recognizes coding sequences of the V region, and the The nucleotide sequence that specifically recognizes the coding sequence of the V region and the second linker are connected to each other; the primers of the first linker include a nucleotide sequence that specifically recognizes the first linker.
其中,所述第一引物群包括多条序列各不相同的第一引物,每条所述第一引物的校对随机段的序列互不相同,每条第一引物包括特异性识别J区一个亚型的编码序列的序列,所述第一引物群包括特异性识别J区所有亚型的编码序列的序列,例如第一引物A包括特异性识别J区A亚型的编码序列的序列,第一引物B包括特异性识别J区B亚型的编码序列的序列,以此类推,第一引物群包括第一引物A、第一引物B等等的引物;所述第二引物群包括多条序列各不相同的第二引物,每条第二引物包括特异性识别V区一个亚型的编码序列的序列,所述第二引物群包括特异性识别V区所有亚型的编码序列的序列,例如第二引物A包括特异性识别V区A亚型的编码序列的序列,第二引物B包括特异性识别V区B亚型的编码序列的序列,以此类推,第二引物群包括第二引物A、第二引物B等等的引物。Wherein, the first primer group includes a plurality of first primers with different sequences, and the sequence of the proofreading random segment of each of the first primers is different from each other, and each of the first primers includes a specific recognition region of the J region. The first primer group includes a sequence that specifically recognizes all subtypes of the J region. For example, the first primer A includes a sequence that specifically recognizes a subtype of the J region A subtype. Primer B includes a sequence that specifically recognizes the coding sequence of the J region B subtype, and so on. The first primer group includes primers of the first primer A, the first primer B, and the like; and the second primer group includes multiple sequences. Different second primers, each of which includes a sequence that specifically recognizes one subtype of the V region, and the second primer group includes a sequence that specifically recognizes all subtypes of the V region, such as The second primer A includes a sequence that specifically recognizes the coding region of the V region A subtype, the second primer B includes the sequence that specifically recognizes the coding region of the V region B subtype, and so on, and the second primer group includes the second primer A, second primer B, etc. The primers.
其中,第一接头和第二接头为构建文库所用的序列,构建的文库包括测序文库或基因文库。The first adaptor and the second adaptor are sequences used to construct a library, and the constructed library includes a sequencing library or a gene library.
其中,所述特异性识别V区的编码序列的核苷酸序列和所述第二接头相互连接。Wherein, the nucleotide sequence of the coding sequence that specifically recognizes the V region and the second linker are connected to each other.
其中,所述J区的编码序列为B细胞受体或T细胞受体的受体编码基因J片段的所有亚型的序列,因此,第一引物群包括特异性识别B细胞受体或T细胞受体的所有亚型的J区的编码序列的核苷酸序列,由于B细胞 受体或T细胞受体的所有亚型的J区的编码序列各不相同,每条所述第一引物的特异性识别J区的编码序列的核苷酸序列的序列互不相同。Wherein, the coding sequence of the J region is a sequence of all subtypes of the J-fragment of the receptor-encoding gene of the B-cell receptor or the T-cell receptor. Therefore, the first primer group includes a specific recognition of the B-cell receptor or the T-cell. The nucleotide sequences of the coding sequences of the J regions of all the subtypes of the receptors are different because the coding sequences of the J regions of all the subtypes of the B cell receptor or the T cell receptor are different. The sequences of the nucleotide sequences that specifically recognize the coding sequence of the J region are different from each other.
其中,所述V区的编码序列为B细胞受体或T细胞受体的受体编码基因V片段的所有亚型的序列,因此,第二引物群包括特异性识别B细胞受体或T细胞受体的所有亚型的V区的编码序列的核苷酸序列,由于B细胞受体或T细胞受体的所有亚型的V区的编码序列各不相同,每条所述第一引物的特异性识别J区的编码序列的核苷酸序列的序列互不相同。Wherein, the coding sequence of the V region is the sequence of all subtypes of the V-fragment of the receptor-encoding gene of the B-cell receptor or the T-cell receptor, therefore, the second primer group includes a specific recognition of the B-cell receptor or the T cell The nucleotide sequences of the coding regions of the V regions of all the subtypes of the receptors are different because the coding sequences of the V regions of all the subtypes of the B cell receptor or the T cell receptor are different. The sequences of the nucleotide sequences that specifically recognize the coding sequence of the J region are different from each other.
作为优选,还包括步骤四,步骤四具体包括:以所述可变区序列组合产物为模板,通过第一测序接头和第二测序接头扩增编码所述可变区的DNA序列,获得可变区序列文库,其中,所述第一测序接头包括特异性识别所述第一接头的核苷酸序列和测序用接头A;所述第二测序接头包括特异性识别所述第二接头的核苷酸序列和测序用接头B,步骤四的目的是对可变区序列组合产物接上高通量测序有需要的测序接头。Preferably, step 4 is further included. The step 4 specifically includes: using the variable region sequence combination product as a template, amplifying a DNA sequence encoding the variable region through a first sequencing adapter and a second sequencing adapter to obtain a variable Region sequence library, wherein the first sequencing linker includes a nucleotide sequence that specifically recognizes the first linker and linker A for sequencing; the second sequencing linker includes a nucleoside that specifically recognizes the second linker Acid sequence and adapter B for sequencing. The purpose of step 4 is to connect the variable region sequence combination product with a sequencing adapter necessary for high-throughput sequencing.
作为优选,所述校对随机段的序列长度为8-20个核苷酸。Preferably, the sequence length of the proofreading random segment is 8-20 nucleotides.
作为优选,所述校对随机段的序列长度为8-10个核苷酸。Preferably, the sequence length of the proofreading random segment is 8-10 nucleotides.
其中,校对随机段的序列长度为8-10个核苷酸,提高第一引物群退火的识别效率,有助于高效的延伸,产物的得率提高。Among them, the sequence length of the proofreading random segment is 8-10 nucleotides, which can improve the recognition efficiency of the first primer group annealing, contribute to efficient extension, and improve the yield of the product.
作为优选,多条所述第一接头的序列互相相同。Preferably, the sequences of the plurality of first linkers are identical to each other.
所述步骤三的扩增为多重PCR,所述多重PCR具体包括:预变性95℃,15s;变性94℃,40s;退火60℃,4min;延伸72℃,90s;终延伸72℃,10s;35个循环。The amplification of the third step is a multiplex PCR, which specifically includes: pre-denaturation 95 ° C, 15s; denaturation 94 ° C, 40s; annealing 60 ° C, 4min; extension 72 ° C, 90s; final extension 72 ° C, 10s; 35 cycles.
其中,以所述DNA样本作为模板,通过第一引物群进行单引物延伸技术编码所述可变区的DNA序列,获得第一扩增产物库,单引物延伸技术可以有效的处理DNA样本,避免RNA样本处理的一些不便利(RNA逆转录时添加接头效率很低),相比需要转换接头的RNA,在效率上也得到了提高。得到单引物延伸后,步骤三的多重PCR只需要在一端利用第一接头引物进行多重PCR,对于多重PCR的效率也是提高的。Wherein, the DNA sample is used as a template, and the single primer extension technology is used to encode the DNA sequence of the variable region by the first primer extension technology to obtain the first amplification product library. The single primer extension technology can effectively process the DNA sample and avoid Some of the inconveniences of RNA sample processing (the efficiency of adding adaptors during reverse transcription of RNA is very low), compared with RNA that needs to convert adaptors, the efficiency is also improved. After the single primer extension is obtained, the multiplex PCR in step 3 only needs to perform multiplex PCR with the first linker primer at one end, and the efficiency of the multiplex PCR is also improved.
作为优选,所述可变区序列为B细胞受体或T细胞受体的可变区序列。Preferably, the variable region sequence is a variable region sequence of a B cell receptor or a T cell receptor.
作为优选,所述含有编码可变区的DNA样本为从动物外周血中提取的全基因组DNA。Preferably, the DNA sample containing the variable region is whole genomic DNA extracted from animal peripheral blood.
作为优选,所述第一引物群的校对随机段的序列相互间不产生引物二聚体,从而提高引入校对随机段的效率。Preferably, the sequences of the proofreading random segments of the first primer group do not generate primer dimers with each other, thereby improving the efficiency of introducing proofreading random segments.
本发明还提供了一种构建可变区序列文库的试剂盒,包括以下引物:第一引物群、第一接头的引物和第二引物群;The present invention also provides a kit for constructing a variable region sequence library, which includes the following primers: a first primer group, a first linker primer, and a second primer group;
其中,所述第一引物群包括特异性识别J区的所有亚型的编码序列的的第一引物;Wherein, the first primer group includes first primers that specifically recognize coding sequences of all subtypes of the J region;
所述第一引物包括特异性识别J区的编码序列的核苷酸序列、校对随机段和第一接头,且所述特异性识别J区的编码序列的核苷酸序列、所述校对随机段和所述第一接头依次连接,所述第一引物群的校对随机段的序列互不相同;The first primer includes a nucleotide sequence that specifically recognizes the coding sequence of the J region, a proofreading random segment, and a first linker, and the nucleotide sequence that specifically recognizes the coding sequence of the J region, and the proofreading random segment. Connected to the first link in sequence, and the sequences of the proofreading random segments of the first primer group are different from each other;
所述第二引物群包括特异性识别V区的所有亚型的编码序列的的第二引物;The second primer group includes second primers that specifically recognize coding sequences of all subtypes of the V region;
所述第二引物包括特异性识别V区的编码序列的核苷酸序列和第二接头,且所述特异性识别V区的编码序列的核苷酸序列和所述第二接头相互连接;The second primer includes a nucleotide sequence that specifically recognizes the coding sequence of the V region and a second linker, and the nucleotide sequence that specifically recognizes the coding sequence of the V region and the second linker are connected to each other;
所述第一接头的引物包括特异性识别第一接头的核苷酸序列。The primer of the first linker includes a nucleotide sequence that specifically recognizes the first linker.
作为优选,编码可变区的DNA样本为T细胞受体的序列,所述第一引物群包括SEQ ID NO:1-13所示核苷酸序列。Preferably, the DNA sample encoding the variable region is a sequence of a T cell receptor, and the first primer group includes a nucleotide sequence shown in SEQ ID NO: 1-13.
作为优选,编码可变区的DNA样本为T细胞受体的序列,所述第二引物群包括SEQ ID NO:14-65所示核苷酸序列。Preferably, the DNA sample encoding the variable region is a sequence of a T cell receptor, and the second primer group includes a nucleotide sequence shown in SEQ ID NO: 14-65.
作为优选,编码可变区的DNA样本为B细胞受体的序列,所述第一引物群包括SEQ ID NO:66-71所示核苷酸序列。Preferably, the DNA sample encoding the variable region is a sequence of a B-cell receptor, and the first primer group includes a nucleotide sequence shown in SEQ ID NOs: 66-71.
作为优选,编码可变区的DNA样本为B细胞受体的序列,所述第二引物群包括SEQ ID NO:72-85所示核苷酸序列。Preferably, the DNA sample encoding the variable region is a sequence of a B-cell receptor, and the second primer group includes a nucleotide sequence shown in SEQ ID NOs: 72-85.
作为优选,所述第一接头为SEQ ID NO:86所示核苷酸序列。Preferably, the first linker is a nucleotide sequence shown in SEQ ID NO: 86.
作为优选,所述第二接头为SEQ ID NO:87所示核苷酸序列,SEQ ID NO:87的序列为:TCGTCGGCAGCGTCAGATGTGTATAAGAGACAG。Preferably, the second linker is a nucleotide sequence shown in SEQ ID NO: 87, and the sequence of SEQ ID NO: 87 is: TCGTCGGCAGCGTCAGATGTGTATAAGAGACAG.
本发明所述的构建可变区序列文库的试剂盒,还包括第一测序接头和第二测序接头;The kit for constructing a variable region sequence library according to the present invention further includes a first sequencing adapter and a second sequencing adapter;
其中,所述第一测序接头包括特异性识别所述第一接头的核苷酸序列和测序用接头A;所述第二测序接头包括特异性识别所述第二接头的核苷酸序列和测序用接头B。Wherein, the first sequencing adapter includes a nucleotide sequence that specifically recognizes the first adapter and sequencing adapter A; the second sequencing adapter includes a nucleotide sequence that specifically recognizes the second adapter and sequencing Use connector B.
作为优选,所述测序用接头A和所述测序用接头B为二代测序仪或三代测序仪的专用引物。Preferably, the linker A for sequencing and the linker B for sequencing are special primers of a second-generation sequencer or a third-generation sequencer.
本发明还提供了一种构建可变区序列文库的试剂盒,包括:SEQ ID NO:1-SEQ ID NO:87的引物组和PCR扩增试剂。The invention also provides a kit for constructing a variable region sequence library, which comprises: a primer set of SEQ ID NO: 1-SEQ ID NO: 87 and a PCR amplification reagent.
其中,PCR扩增试剂包括PCR常用的酶、NTPs、Buffer和缓冲剂。Among them, PCR amplification reagents include enzymes, NTPs, Buffer and buffers commonly used in PCR.
本发明还公开了一种可变区序列的测序方法,包括如所述的方法或如所述的构建可变区序列文库的试剂盒,构建得到可变区序列文库;以及,对所述可变区测序文库进行高通量测序,得到可变区序列。The invention also discloses a method for sequencing a variable region sequence, comprising the method as described above or a kit for constructing a variable region sequence library as described, and constructing a variable region sequence library; and The variable region sequencing library was subjected to high-throughput sequencing to obtain variable region sequences.
任选地,根据接头引物的序列,所述高通量测序是利用选自Hiseq、Miseq、454、SOLiD、Ion Torrent以及CG测序平台的至少之一进行的,本发明实施例的接头引物为illumina测序引物。Optionally, according to the sequence of the adaptor primer, the high-throughput sequencing is performed using at least one selected from the group consisting of Hiseq, Miseq, 454, SOLiD, Ion Torrent, and CG sequencing platform. The adaptor primer of the embodiment of the present invention is illumina Sequencing primers.
其中,校对随机段具体包括随机合成的DNA序列。The proofreading random segment specifically includes a randomly synthesized DNA sequence.
本发明还公开了可变区序列文库的构建方法在TCR/BCR的精准分析的文库建立方法中的应用。The invention also discloses the application of a method for constructing a variable region sequence library in a method for accurately analyzing a TCR / BCR library.
本发明的目的针对现有的利用DNA和RNA构建TCR或者BCR的可变区序列文库技术的不足,所公开的的一种可变区序列文库的构建方法,包括三个步骤:步骤一、获得含有编码可变区的DNA样本;步骤二、以所述DNA样本作为模板,通过第一引物群延伸编码所述可变区的DNA序列,获得第一扩增产物库,其中,所述第一引物群包括多条序列各不相同的第一引物,所述第一引物包括特异性识别J区的编码序列的核苷酸序列、 校对随机段和第一接头,且所述特异性识别J区的编码序列的核苷酸序列、所述校对随机段和所述第一接头依次连接,每条所述第一引物的校对随机段的序列互不相同,每条所述特异性识别J区的编码序列的核苷酸序列包括特异性识别一个亚型的J区的编码序列的序列,所述第一引物群包括特异性识别所有亚型的J区的编码序列的序列;步骤三、以所述第一扩增产物库作为模板,通过第二引物群和第一接头的引物扩增编码所述可变区的DNA序列,获得可变区序列组合产物,其中,所述第二引物群包括多条序列各不相同的第二引物,所述第二引物包括特异性识别V区的编码序列的核苷酸序列和第二接头,所述第一接头的引物包括特异性识别第一接头的核苷酸序列,每条所述特异性识别V区的编码序列的核苷酸序列包括特异性识别一个亚型的V区的编码序列的序列,所述第二引物群包括特异性识别所有亚型的V区的编码序列的序列。校对随机段相当于一种random barcode,在步骤二中通过延伸添加到DNA样本中,在构建可变区文库后需要进行高通量测序得到可变区文库的完整序列,在此过程中,进行测序时会对可变区序列组合产物进行多次PCR,从而引入不同的PCR错误,在DNA样本中添加校对随机段,由于每一个模板都带有一个独特的随机片段,即为一一对应关系,在PCR过程中,该部分随机片段与连接的PCR片段同时扩增,得到大量的扩增子。而当大量的扩增中有部分PCR片段为PCR错误引入的突变存在的情况下,由于一一对应的关系,可以利用同一随机片段识别的其他正确正确PCR产物进行较偏,把那些突变产物较偏(正确率大于50%认定为正确的PCR产物);同时,因为校对随机段的引入,使得每一个模板都带有一个独特的校对随机段,当选定固定数目的校对随机段的数据量进行样品之间的比较,在免疫细胞受体多态性的检测中,只有在同一有效数据下的比较才能更好地实现多态性的评估以及个体之间多态性的比较,因此,本发明的方法可以实现不同样品间的比较。此外,在步骤三中通过第二引物和第一接头的引物扩增编码所述可变区的DNA序列,第一接头的引物为单一引物,第二引物群包括特异性识别V区的编码序列的核苷酸序列和第二接头,所以,进行1对多的多重PCR,能确保步骤三的扩增效率以及获得可变区序列组合产物的得率。且本发明选用DNA样本可以实现每一个T细胞或者B细胞对应一个特有的TCR或者 BCR的一一对应关系,有利于全面评估机体的TCR或者BCR的多样性。The purpose of the present invention is to address the shortcomings of the existing technology for constructing a variable region sequence library of TCR or BCR by using DNA and RNA. The disclosed method for constructing a variable region sequence library includes three steps: step one, obtaining A DNA sample containing a variable region is encoded; step two, using the DNA sample as a template, extending a DNA sequence encoding the variable region through a first primer group to obtain a first amplified product library, wherein the first The primer group includes a plurality of first primers each having a different sequence, the first primer includes a nucleotide sequence that specifically recognizes a coding sequence of the J region, a proofreading random segment, and a first linker, and the specifically recognizes the J region The nucleotide sequence of the coding sequence, the proofreading random segment and the first linker are connected in sequence. The sequence of the proofreading random segment of each of the first primers is different from each other. The nucleotide sequence of the coding sequence includes a sequence of a coding sequence that specifically recognizes a subtype of the J region, and the first primer group includes a sequence of a coding sequence that specifically recognizes all the subtypes of the J region; step three. Describe An amplification product library is used as a template, and a DNA sequence encoding the variable region is amplified by primers of a second primer group and a first adaptor to obtain a variable region sequence combination product, wherein the second primer group includes a plurality of A second primer having a different sequence, the second primer including a nucleotide sequence that specifically recognizes the coding sequence of the V region and a second linker, and the primer of the first linker includes a nucleoside that specifically recognizes the first linker Acid sequence, the nucleotide sequence of each coding sequence that specifically recognizes the V region includes a sequence that specifically recognizes a subtype of the V region, and the second primer group includes a sequence that specifically recognizes all subtypes The sequence of the coding sequence of the V region. Proofreading the random segment is equivalent to a kind of random barcode. In step two, it is added to the DNA sample by extension. After constructing the variable region library, high-throughput sequencing is needed to obtain the complete sequence of the variable region library. In this process, During sequencing, multiple PCR products of the variable region sequence are combined to introduce different PCR errors, and a proofreading random segment is added to the DNA sample. Each template has a unique random segment, which is a one-to-one correspondence. In the process of PCR, this part of the random fragment is amplified simultaneously with the connected PCR fragment to obtain a large number of amplicons. However, when a large number of PCR fragments have mutations introduced by PCR errors, due to the one-to-one correspondence, other correct and correct PCR products identified by the same random fragment can be used to bias the mutation products. Partial (correctness rate is greater than 50% is considered correct PCR product); At the same time, due to the introduction of proofreading random segments, each template has a unique proofreading random segment. When a fixed number of proofreading random segments are selected, the amount of data Comparison between samples. In the detection of immune cell receptor polymorphisms, only the comparison under the same valid data can better achieve the assessment of polymorphisms and the comparison of polymorphisms among individuals. Therefore, the present The inventive method enables comparisons between different samples. In addition, in step three, the DNA sequence encoding the variable region is amplified by a second primer and a primer of the first linker. The primer of the first linker is a single primer, and the second primer group includes a coding sequence that specifically recognizes the V region. Nucleotide sequence and the second linker, so performing a one-to-many multiplex PCR can ensure the amplification efficiency of step three and the yield of the combined product of the variable region sequences. In addition, the use of a DNA sample in the present invention can realize a one-to-one correspondence between each T cell or B cell corresponding to a unique TCR or BCR, which is beneficial to comprehensively evaluate the diversity of the TCR or BCR of the body.
附图说明BRIEF DESCRIPTION OF THE DRAWINGS
为了更清楚地说明本发明实施例或现有技术中的技术方案,下面将对实施例或现有技术描述中所需要使用的附图作简单地介绍。In order to explain the technical solutions in the embodiments of the present invention or the prior art more clearly, the drawings used in the description of the embodiments or the prior art will be briefly introduced below.
图1示本发明的可变区序列文库的构建方法的流程示意图;FIG. 1 shows a schematic flowchart of a method for constructing a variable region sequence library according to the present invention;
图2示本发明的校正随机段的较偏过程示意图;FIG. 2 is a schematic diagram of a bias process of correcting a random segment according to the present invention; FIG.
图3示本发明提供的实施例1的TCR独特克隆数分析;FIG. 3 shows the TCR unique clone number analysis of Example 1 provided by the present invention; FIG.
图4示本发明提供的实施例1的BCR独特克隆数分析;Figure 4 shows the analysis of the number of unique clones of BCR in Example 1 provided by the present invention;
其中,含有编码可变区的DNA样本1、J区的编码序列11、V区的编码序列12、第一接头2、校对随机段3、特异性识别J区的编码序列的核苷酸序列4、第一扩增产物库5、第二接头6、特异性识别V区的编码序列的核苷酸序列7、可变区序列组合产物8、第一接头的引物9、第二测序接头10、可变区序列文库11、第一测序接头12。Among them, a DNA sample containing a variable region 1, a coding sequence of the J region 11, a coding sequence of the V region 12, a first linker 2, a proofreading random segment 3, and a nucleotide sequence that specifically recognizes the coding sequence of the J region 4 First library of amplification products 5, second adapter 6, nucleotide sequence that specifically recognizes the coding sequence of the V region 7, variable region sequence combination product 8, primers for the first adapter 9, second sequencing adapter 10, Variable region sequence library 11, first sequencing adapter 12.
具体实施方式Detailed ways
本发明提供了构建可变区序列文库试剂盒及可变区序列文库构建方法,用于解决目前构建TCR或者BCR的可变区序列文库技术存在的扩增效率低、扩增存在偏倚性以及容易丢失可变区序列文库序列信息的技术缺陷。The invention provides a kit for constructing a variable region sequence library and a method for constructing a variable region sequence library, which are used to solve the low amplification efficiency, bias, and ease of amplification existing in the current technology for constructing variable region sequence libraries of TCR or BCR. Technical shortcomings of losing sequence information from variable region sequence libraries.
下面将对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。The technical solutions in the embodiments of the present invention will be clearly and completely described below. Obviously, the described embodiments are only a part of the embodiments of the present invention, but not all the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by a person of ordinary skill in the art without creative efforts shall fall within the protection scope of the present invention.
请参阅图1,本发明公开了一种可变区序列文库的构建方法,包括以下步骤:Referring to FIG. 1, the present invention discloses a method for constructing a variable region sequence library, which includes the following steps:
步骤一、获得含有编码可变区的DNA样本1;Step 1: Obtain a DNA sample 1 containing a variable region encoding;
步骤二101、以所述DNA样本1作为模板,通过第一引物群延伸编码所述可变区的DNA序列,获得第一扩增产物库5,其中,第一引物群包括 多条各不相同的第一引物,第一引物包括特异性识别J区的编码序列的核苷酸序列4、校对随机段3和第一接头2,且特异性识别J区的编码序列的核苷酸序列4、校对随机段3和第一接头2依次连接,每条第一引物的校对随机段3的序列互不相同,每条特异性识别J区的编码序列的核苷酸序列包括特异性识别一个亚型的J区的编码序列的序列,第一引物群包括特异性识别所有亚型的J区的编码序列的序列;Step two 101: Use the DNA sample 1 as a template to extend the DNA sequence encoding the variable region through a first primer group to obtain a first amplification product library 5, where the first primer group includes a plurality of different ones. The first primer includes a nucleotide sequence 4 that specifically recognizes the coding sequence of the J region, a proofreading random segment 3 and a first linker 2, and a nucleotide sequence 4 that specifically recognizes the coding sequence of the J region. The proofreading random segment 3 and the first adaptor 2 are connected in sequence. The sequences of the proofreading random segment 3 of each first primer are different from each other. The nucleotide sequence of each coding sequence that specifically recognizes the J region includes specifically identifying a subtype. Sequence of the coding sequence of the J region, the first primer group includes a sequence of coding sequences that specifically recognize all subtypes of the J region;
步骤三102、以第一扩增产物库作为模板,通过第二引物群和第一接头的引物9扩增编码可变区的DNA序列,获得可变区序列组合产物8,其中,第二引物群包括多条序列各不相同的第二引物,第二引物包括特异性识别V区的编码序列的核苷酸序列7和第二接头6,第一接头的引物9包括特异性识别第一接头2的核苷酸序列,每条特异性识别V区的编码序列的核苷酸序列包括特异性识别一个亚型的V区的编码序列的序列,第二引物群包括特异性识别所有亚型的V区的编码序列的序列。Step 3: 102. Using the first amplification product library as a template, the DNA sequence encoding the variable region is amplified by the second primer group and the primer 9 of the first linker to obtain a variable region sequence combination product 8. Among them, the second primer The group includes a plurality of second primers with different sequences. The second primer includes a nucleotide sequence 7 and a second linker 6 that specifically recognize the coding sequence of the V region. The primer 9 of the first linker includes the first linker that specifically recognizes the first linker. 2 nucleotide sequence, each nucleotide sequence that specifically recognizes the coding sequence of the V region includes a sequence that specifically recognizes a subtype of the V region, and the second primer group includes a sequence that specifically recognizes all subtypes The sequence of the coding sequence of the V region.
进一步的,本发明实施例还包括步骤四103,步骤四103具体包括:以可变区序列组合产物8为模板,通过第一测序接头12和第二测序接头接头10扩增编码所述可变区的DNA序列,获得可变区序列文库11,其中,第一测序接头包括特异性识别第一接头的核苷酸序列和测序用接头A;第二测序接头10包括特异性识别第二接头的核苷酸序列和测序用接头B。Further, the embodiment of the present invention further includes step 4103. Step 4103 specifically includes: using the variable region sequence combination product 8 as a template, and amplifying and encoding the variable through the first sequencing adapter 12 and the second sequencing adapter adapter 10. The variable region sequence library 11 is obtained, wherein the first sequencing linker includes a nucleotide sequence that specifically recognizes the first linker and the linker A for sequencing; the second sequencing linker 10 includes a linker that specifically recognizes the second linker. Nucleotide sequence and adapter B for sequencing.
其中,以下实施例所用原料均为市售或自制。The raw materials used in the following examples are all commercially available or homemade.
实施例1Example 1
本发明实施例提供一种构建可变区序列文库的具体方法,其步骤如下:The embodiment of the present invention provides a specific method for constructing a variable region sequence library. The steps are as follows:
一:模板准备1: template preparation
1、采集人体外周血5-10ml于抗凝管中;1. Collect 5-10ml of human peripheral blood in anticoagulant tube;
2、将收到的新鲜血液加入三倍体积的RBC lysis buffer,轻柔的翻转离心管使其混合均匀;2. Add the fresh blood received to three times the volume of RBC analysis buffer, and gently turn the centrifuge tube to make it mix well;
3、常温下静置反应15分钟;3. Let stand for 15 minutes at room temperature;
4、以450xg离心10分钟,将上清液小心地去除,留下细胞沉淀pellet;4. Centrifuge at 450xg for 10 minutes, carefully remove the supernatant, and leave the pellet of cells;
5、若pellet还有明显红色可再加入原来血液体积两倍的RBC lysis buffer,重复步骤2与步骤3;5. If the pellet is still red, add RBC analysis buffer with twice the original blood volume, and repeat steps 2 and 3.
6、以600μl PBS将pellet均匀悬浮,取200μl以TIANamp Genomics  DNAkit进行DNA萃取;6. Suspend pellets with 600μl PBS, take 200μl DNA extraction with TIANamp Genomics DNAkit;
7、引物Primer准备:7. Primer preparation:
7.1、引物Primer共有52条TRBV、13条TRBJ random、14条IgHV、6条IgHJ random、1条overhang,全部回溶为100μM做为stock primer(储存引物)。7.1 Primer Primer has 52 TRBV, 13 TRBJ random, 14 IgHV, 6 IgHJ random, 1 overhang, all reconstituted to 100 μM as stock primer (storage primer).
7.2、如表1所示,52条TRBV各取1μl稀释到48μl ddH 2O中,配制成100μl的TRBV工作引物,第二引物为TRBV工作引物,第二引物包括SEQ ID NO:14-65所示核苷酸序列; 7.2. As shown in Table 1, each of the 52 TRBVs was diluted into 48 μl ddH 2 O into 48 μl ddH 2 O to prepare 100 μl TRBV working primers. The second primer was the TRBV working primer. The second primer included SEQ ID NO: 14-65. Display nucleotide sequence;
7.3、如表2所示,13条TRBJ random各取3μl稀释到11μl ddH 2O,配制成50μl的TRBJ random工作引物,其中random为校对随机段,random的片段数为18个核苷酸,第一引物群为TRBJ random工作引物,TRBJ random工作引物包括SEQ ID NO:1-13所示核苷酸序列; 7.3. As shown in Table 2, 13 TRBJ random samples were each diluted with 3 μl to 11 μl ddH 2 O, and were prepared into 50 μl TRBJ random working primers, in which random is a proofreading random segment, and the number of random fragments is 18 nucleotides. A primer group is a working primer of TRBJ random, and a working primer of TRBJ random includes a nucleotide sequence shown in SEQ ID NOs: 1-13;
7.4、如表3所示,14条IgHV各取1μl稀释到36μl ddH 2O,配制成50μl的IgHV工作引物,第二引物为IgHV工作引物,IgHV工作引物包括SEQ ID NO:72-85所示核苷酸序列; 7.4. As shown in Table 3, 14 IgHV samples were each diluted to 36 μl ddH 2 O to prepare 50 μl IgHV working primers. The second primer was the IgHV working primer. The IgHV working primers are shown in SEQ ID NOs: 72-85. Nucleotide sequence
7.5、如表4所示,6条IgHJ random各取3μl稀释到32ul ddH 2O,配制成50μl的IghJ random工作引物,其中random为校对随机段,random的片段数为18个核苷酸,第一引物群为IghJ random工作引物,IghJ random工作引物包括SEQ ID NO:66-71所示核苷酸序列; 7.5. As shown in Table 4, 6 IgHJ random samples were each diluted with 3 μl to 32 ul ddH 2 O, and 50 μl IghJ random working primers were prepared, in which random is a proofreading random segment, and the number of random fragments is 18 nucleotides. A primer group is an IghJ random working primer, and the IghJ random working primer includes a nucleotide sequence shown in SEQ ID NOs: 66-71;
7.6、如表5所示,Overhang做10×稀释(10μM),配制成50μl的overhang工作引物,第一接头为Overhang,第一接头为SEQ ID NO:86所示核苷酸序列,第二接头为SEQ ID NO:87所示核苷酸序列。7.6. As shown in Table 5, Overhang made a 10 × dilution (10 μM) to prepare 50 μl of the overhang working primer. The first linker was Overhang, the first linker was the nucleotide sequence shown in SEQ ID NO: 86, and the second linker. It is the nucleotide sequence shown in SEQ ID NO: 87.
其中,需要说明的是,TRB是T细胞受体的重链,该部分序列含有决定T细胞受体多样性的CDR3区域。IgH是B细胞受体的重链,该部分序列含有决定B细胞受体多样性的CDR3区域。It should be noted that TRB is a heavy chain of the T cell receptor, and this partial sequence contains a CDR3 region that determines the diversity of the T cell receptor. IgH is the heavy chain of B-cell receptors, and this partial sequence contains CDR3 regions that determine the diversity of B-cell receptors.
表1 TRBV工作引物Table 1.TRBV working primers
Figure PCTCN2018088989-appb-000001
Figure PCTCN2018088989-appb-000001
Figure PCTCN2018088989-appb-000002
Figure PCTCN2018088989-appb-000002
Figure PCTCN2018088989-appb-000003
Figure PCTCN2018088989-appb-000003
Figure PCTCN2018088989-appb-000004
Figure PCTCN2018088989-appb-000004
Figure PCTCN2018088989-appb-000005
Figure PCTCN2018088989-appb-000005
Figure PCTCN2018088989-appb-000006
Figure PCTCN2018088989-appb-000006
Figure PCTCN2018088989-appb-000007
Figure PCTCN2018088989-appb-000007
表4 IghJ random工作引物(下表中的N为校对随机段的核苷酸)Table 4 IghJ random primers (N in the table below is the nucleotide of the proofreading random segment)
Figure PCTCN2018088989-appb-000008
Figure PCTCN2018088989-appb-000008
Figure PCTCN2018088989-appb-000009
Figure PCTCN2018088989-appb-000009
表5table 5
引物名称Primer name 编号Numbering 序列(5’-3’)Sequence (5’-3 ’)
SEQ ID NO:86SEQ ID NO: 86 Overhang(第一接头)Overhang (first connector) GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAG
二:第一次PCR(退火+延伸):2: The first PCR (annealing + extension):
1、PCR配制(TRB J区延伸)1.PCR preparation (TRB and J zone extension)
成分ingredient 体积volume
Phusion 2×MMPhusion 2 × MM 10μl10μl
TRBJ random工作引物TRBJ Random Work Primer 2μl2μl
100ng DNA+ddH 2O 100ng DNA + ddH 2 O 8μl8μl
TotalTotal 20μl20μl
PCR配制(IgH J区延伸)PCR preparation (IgH and J zone extension)
成分ingredient 体积volume
Phusion 2×MMPhusion 2 × MM 10μl10μl
IghJ random工作引物IghJ Random Work Primer 2μl2μl
100ng DNA+ddH 2O 100ng DNA + ddH 2 O 8μl8μl
TotalTotal 20μl20μl
2、第一次PCR程序:2. The first PCR program:
Figure PCTCN2018088989-appb-000010
Figure PCTCN2018088989-appb-000010
3、第一次磁珠纯化:3. The first magnetic bead purification:
3.1、前置作业:AMPure XP使用前回温到室温,分装到tube使用;体积浓度为80%酒精需新鲜配制;Purify使用1.5ml离心管或是200μl以上的96孔盘。3.1. Pre-operation: AMPure XP should be warmed to room temperature before use and divided into tubes for use; 80% alcohol by volume should be prepared freshly; Purify uses 1.5ml centrifuge tubes or 96-well plates with 200μl or more.
3.2、以体积1.5:1的方式混合AMPure XP Beads和第一次PCR的产物 (30μl AMPure Beads+20μl PCR产物),吹打至少10次,使其充分混合。3.2. Mix AMPure XP Beads and the products of the first PCR (30 μl AMPure Beads + 20 μl PCR products) in a volume of 1.5: 1, and mix by pipetting at least 10 times.
3.3、室温下孵育10mins;3.3 Incubate at room temperature for 10mins;
3.4、将3.3的离心管放到磁座上2mins或等到液体澄清;3.4 Place the centrifuge tube of 3.3 on the magnetic stand for 2mins or wait until the liquid is clear;
3.5、吸去上清液并丢弃,小心不要吸到磁珠。可将吸液量调整到比总体积少5μl去吸取;3.5. Aspirate the supernatant and discard. Be careful not to suck the magnetic beads. The amount of aspiration can be adjusted to 5 μl less than the total volume for aspiration;
3.6、保持离心管在磁座上,加入200μl体积浓度为80%乙醇,室温孵育30secs,将所有的上清液吸除并丢弃;3.6 Keep the centrifuge tube on the magnetic stand, add 200 μl of 80% ethanol in volume concentration, and incubate at room temperature for 30 secs. Aspirate and discard all the supernatant;
3.7、重复步骤3.6一次(总共有两次的80%乙醇洗涤);3.7. Repeat step 3.6 once (there are two 80% ethanol washings);
3.8、以较细的吸管将残余的溶液吸除干净;3.8. Absorb the remaining solution with a thin straw;
3.9、室温干燥离心管10mins;3.9, dry the centrifuge tube at room temperature for 10mins;
3.10、将离心管拿离磁座,加入20μl Resuspension buffer,吹打至少10次,使其充分混合;3.10. Remove the centrifuge tube from the magnetic base, add 20 μl Resuspension buffer, and blow at least 10 times to fully mix;
3.11、室温下孵育2mins;3.11 Incubate at room temperature for 2mins;
3.12、将3.11离心管放到磁座上2mins或等到液体澄清;3.12 Place the 3.11 centrifuge tube on the magnetic stand for 2mins or wait until the liquid is clear;
3.13、将17.5μl上清液吸到新的离心管保存。3.13. Aspirate 17.5 μl of the supernatant into a new centrifuge tube for storage.
三、第二次PCR:Third, the second PCR:
1、多重PCR体系(TRB V区进行多重PCR):1. Multiplex PCR system (multiplex PCR in TRB region):
成分ingredient 体积volume
Qiagen Multiplex PCR 2×MMQiagen Multiplex PCR 2 × MM 25μl25μl
TRBV工作引物TRBV working primer 5μl5μl
overhang工作引物overhang working primer 2.52.5
100ng DNA+ddH2O100ng DNA + ddH2O 17.5μl17.5 μl
TotalTotal 50μl50μl
多重PCR体系(Igh V区进行多重PCR):Multiplex PCR system (multiplex PCR in Igh and V regions):
成分ingredient 体积volume
Qiagen Multiplex PCR 2×MMQiagen Multiplex PCR 2 × MM 25μl25μl
IghJ工作引物IghJ working primer 5μl5μl
overhang工作引物overhang working primer 2.52.5
100ng DNA+ddH2O100ng DNA + ddH2O 17.5μl17.5 μl
TotalTotal 50μl50μl
2、多重PCR程序:2. Multiplex PCR program:
Figure PCTCN2018088989-appb-000011
Figure PCTCN2018088989-appb-000011
3、第二次磁珠纯化与size selection:3. The second magnetic bead purification and size selection:
3.1、前置作业:AMPure XP使用前回温到室温,分装到tube使用;体积浓度为80%酒精需新鲜配制;Purify使用1.5ml离心管或是200μl以上的96孔盘。3.1. Pre-operation: AMPure XP should be warmed to room temperature before use and divided into tubes for use; 80% alcohol by volume should be prepared freshly; Purify uses 1.5ml centrifuge tubes or 96-well plates with 200μl or more.
3.2、以体积0.9:1的方式混合AMPure XP Beads和第二次PCR产物(36μl AMPure Beads+40μl PCR产物),吹打至少10次,使其充分混合。3.2. Mix AMPure XPBeads and the second PCR product (36μl AMPureBeads + 40μl PCR product) in a volume of 0.9: 1, and mix by blowing at least 10 times.
3.3、室温下孵育10mins。3.3 Incubate at room temperature for 10mins.
3.4、将离心管放到磁座上2mins或等到液体澄清。3.4 Place the centrifuge tube on the magnetic stand for 2mins or wait until the liquid is clear.
3.5、将70μl上清液移到新的离心管。3.5. Transfer 70 μl of the supernatant to a new centrifuge tube.
3.6、以体积1:1的方式混合AMPure XP Beads和前一步骤所取得的上清液(70μl AMPure Beads+70μl上清液),吹打至少10次,使其充分混合。3.6. Mix AMPure XP Beads and the supernatant obtained in the previous step (70 μl AMPure Beads + 70 μl supernatant) in a volume of 1: 1, and pipette at least 10 times to fully mix.
3.7、室温下孵育10mins。3.7 Incubate at room temperature for 10mins.
3.8、将离心管放到磁座上2mins或等到液体澄清。3.8 Place the centrifuge tube on the magnetic stand for 2mins or wait until the liquid is clear.
3.9、吸去上清液并丢弃,小心不要吸到磁珠。可将吸液量调整到比总体积少5μl去吸。3.9 Aspirate the supernatant and discard. Be careful not to suck the magnetic beads. The amount of aspiration can be adjusted to 5 μl less than the total volume for aspiration.
3.10、保持离心管在磁座上,加入200μl体积浓度为80%乙醇,室温孵育30secs,将所有的上清液吸除并丢弃。3.10. Keep the centrifuge tube on the magnetic base, add 200 μl of 80% ethanol in volume concentration, and incubate at room temperature for 30secs. Aspirate and discard all the supernatant.
3.11、重复步骤3.10一次(总共有两次的体积浓度为80%乙醇洗涤)。3.11. Repeat step 3.10 once (there are two washings with a volume concentration of 80% ethanol).
3.12、以较细的吸管将残余的溶液吸除干净。3.12. Remove the residual solution with a thin pipette.
3.13、室温干燥离心管10mins。3.13 Dry the centrifuge tube at room temperature for 10mins.
3.14、将离心管拿离磁座,加入17.5μl Resuspension buffer,吹打至少 10次,使其充分混合。3.14. Remove the centrifuge tube from the magnetic base, add 17.5 μl Resuspension buffer, and blow at least 10 times to mix thoroughly.
3.15、室温下孵育2mins。3.15. Incubate at room temperature for 2mins.
3.16、将离心管放到磁座上2mins或等到液体澄清。3.16. Place the centrifuge tube on the magnetic stand for 2mins or wait until the liquid is clear.
3.17、将15μl上清液吸到新的PCR管保存。3.17. Aspirate 15 μl of the supernatant into a new PCR tube for storage.
四、第三次PCR:Fourth, the third PCR:
1、建库PCR体系配制(TRB建库):1. Preparation of library PCR system (TRB library):
成分ingredient 体积volume
Phusion 2×MMPhusion 2 × MM 25μl25μl
测序引物1Sequencing Primer 1 5μl5μl
测序引物2Sequencing Primer 2 5μl5μl
100ng First elution DNA+ddH2O100ng First elution DNA + ddH2O 15μl15μl
TotalTotal 50μl50μl
建库PCR体系配制(Igh建库)Preparation of library PCR system (Igh library)
成分ingredient 体积volume
Phusion 2×MMPhusion 2 × MM 25μl25μl
测序引物1Sequencing Primer 1 5μl5μl
测序引物2Sequencing Primer 2 5μl5μl
100ng First elution DNA+ddH2O100ng First elution DNA + ddH2O 15μl15μl
TotalTotal 50μl50μl
其中,测序引物1包括特异性识别第一接头的核苷酸序列(SEQ ID NO:86)和测序用接头A;测序引物2包括特异性识别第二接头的核苷酸序列(SEQ ID NO:87)和测序用接头B,测序用接头A和测序用接头B为illumina测序仪专用引物。Among them, sequencing primer 1 includes a nucleotide sequence that specifically recognizes the first linker (SEQ ID NO: 86) and sequencing linker A; sequencing primer 2 includes a nucleotide sequence that specifically recognizes the second linker (SEQ ID NO: 87) and Sequencing adapter B, Sequencing adapter A and Sequencing adapter B are primers for illumina sequencer.
2、建库PCR程序:2. Library PCR program:
Figure PCTCN2018088989-appb-000012
Figure PCTCN2018088989-appb-000012
Figure PCTCN2018088989-appb-000013
Figure PCTCN2018088989-appb-000013
3、第三次磁珠纯化:3. The third magnetic bead purification:
3.1、前置作业:AMPure XP使用前回温到室温,分装到离心管使用;体积浓度为80%酒精需新鲜配制;Purify使用1.5ml离心管或是200μl以上的96孔盘。3.1. Pre-operation: AMPure XP is warmed to room temperature before use, and aliquoted into a centrifuge tube; 80% alcohol by volume must be freshly prepared; Purify uses a 1.5ml centrifuge tube or a 96-well plate with 200μl or more.
3.2、以体积1:1的方式混合AMPure XP Beads和第三次PCR产物(50μl AMPure Beads+50μl第三次PCR产物),吹打至少10次,使其充分混合。3.2. Mix AMPure XP Beads and the third PCR product (50 μl AMPure Beads + 50 μl third PCR product) in a volume of 1: 1, and blow at least 10 times to mix thoroughly.
3.3、室温下孵育10mins。3.3 Incubate at room temperature for 10mins.
3.4、将离心管放到磁座上2mins或等到液体澄清。3.4 Place the centrifuge tube on the magnetic stand for 2mins or wait until the liquid is clear.
3.5、吸去上清液并丢弃,小心不要吸到磁珠。可将吸液量调整到比总体积少5μl去吸取。3.5. Aspirate the supernatant and discard. Be careful not to suck the magnetic beads. The amount of pipette can be adjusted to 5μl less than the total volume for pipetting.
3.6、保持离心管在磁座上,加入200μl体积浓度为80%乙醇,室温孵育30secs,将所有的上清液吸除并丢弃。3.6. Keep the centrifuge tube on the magnetic base, add 200 μl of 80% ethanol in volume concentration, and incubate at room temperature for 30 secs. Aspirate and discard all the supernatant.
3.7、重复步骤3.6一次(总共有两次的体积浓度为80%乙醇洗涤)。3.7. Repeat step 3.6 once (there are two washings with a volume concentration of 80% ethanol).
3.8、以较细的吸管将残余的溶液吸除干净。3.8. Absorb the remaining solution with a thin pipette.
3.9、室温干燥离心管10mins。3.9. Dry the centrifuge tube at room temperature for 10mins.
3.10、将离心管拿离磁座,加入22.5μl Resuspension buffer,吹打至少10次,使其充分混合。3.10. Remove the centrifuge tube from the magnetic base, add 22.5 μl Resuspension buffer, and blow at least 10 times to mix thoroughly.
3.11、室温下孵育2mins。3.11 Incubate at room temperature for 2mins.
3.12、将离心管放到磁座上2mins或等到液体澄清。3.12 Place the centrifuge tube on the magnetic stand for 2mins or wait until the liquid is clear.
3.13、将20μl上清液吸到新的离心管保存。3.13. Aspirate 20 μl of the supernatant into a new centrifuge tube for storage.
对比例Comparative example
一、Primer准备I. Primer preparation
对比例的引物共有52条TRBV、13条TRBJ、14条IgHV、6条IgHJ、全部回溶为100μM做为stock primer(储存引物)。如表1所示,52条TRBV各取1μl稀释到48μl ddH 2O中,配制成100μl的TRBV工作引物;如表6所示,13条TRBJ各取3μl稀释到11μl ddH 2O,配制成50μl的TRBJ工作引物;如表3所示,14条IgHV各取1μl稀释到36μl ddH 2O,配制成50μl的IgHV工作引物;如表7所示,6条IgHJ各取3μl稀释到32μl ddH 2O, 配制成50μl的IghJ工作引物。 The primers of the comparative example had 52 TRBV, 13 TRBJ, 14 IgHV, 6 IgHJ, all of which were reconstituted to 100 μM as stock primer (storage primer). As shown in Table 1, 52 TRBVs were each diluted by 1 μl into 48 μl ddH 2 O to prepare 100 μl TRBV working primers; as shown in Table 6, 13 TRBJs were each diluted by 3 μl and diluted to 11 μl ddH 2 O, and prepared into 50 μl. TRBJ working primers; as shown in Table 3, 14 IgHVs were each diluted to 36 μl ddH 2 O to prepare 50 μl IgHV working primers; as shown in Table 7, 6 IgHJs were each diluted to 3 μl to 32 μl ddH 2 O , Formulated into 50μl IghJ working primer.
表6 TRBJ工作引物Table 6 TRBJ working primers
引物名称Primer name 序列(5’-3’)Sequence (5’-3 ’)
TRBJ1-1TRBJ1-1 GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGTTACCTACAACTGTGAGTCTGGTGCCTTGTCCAAAGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGTTACCTACAACTGTGAGTCTGGTGCCTTGTCCAAA
TRBJ1-2TRBJ1-2 GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGACCTACAACGGTTAACCTGGTCCCCGAACCGAAGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGACCTACAACGGTTAACCTGGTCCCCGAACCGAA
TRBJ1-3TRBJ1-3 GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGACCTACAACAGTGAGCCAACTTCCCTCTCCAAAGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGACCTACAACAGTGAGCCAACTTCCCTCTCCAAA
TRBJ1-4TRBJ1-4 GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCCAAGACAGAGAGCTGGGTTCCACTGCCAAAGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCCAAGACAGAGAGCTGGGTTCCACTGCCAAA
TRBJ1-5TRBJ1-5 GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGACCTAGGATGGAGAGTCGAGTCCCATCACCAAAGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGACCTAGGATGGAGAGTCGAGTCCCATCACCAAA
TRBJ1-6TRBJ1-6 GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCTGTCACAGTGAGCCTGGTCCCGTTCCCAAAGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCTGTCACAGTGAGCCTGGTCCCGTTCCCAAA
TRBJ2-1TRBJ2-1 GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCGGTGAGCCGTGTCCCTGGCCCGAAGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCGGTGAGCCGTGTCCCTGGCCCGAA
TRBJ2-2TRBJ2-2 GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCCAGTACGGTCAGCCTAGAGCCTTCTCCAAAGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCCAGTACGGTCAGCCTAGAGCCTTCTCCAAA
TRBJ2-3TRBJ2-3 GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGACTGTCAGCCGGGTGCCTGGGCCAAAGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGACTGTCAGCCGGGTGCCTGGGCCAAA
TRBJ2-4TRBJ2-4 GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGAGAGCCGGGTCCCGGCGCCGAAGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGAGAGCCGGGTCCCGGCGCCGAA
TRBJ2-5TRBJ2-5 GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGGAGCCGCGTGCCTGGCCCGAAGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGGAGCCGCGTGCCTGGCCCGAA
TRBJ2-6TRBJ2-6 GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGTCAGCCTGCTGCCGGCCCCGAAGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGTCAGCCTGCTGCCGGCCCCGAA
TRBJ2-7TRBJ2-7 GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGTGAGCCTGGTGCCCGGCCCGAAGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGTGAGCCTGGTGCCCGGCCCGAA
表7 IghJ工作引物Table 7 IghJ working primers
IgHJ1IgHJ1 GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCAGTGCTGGAAGTATTCAGCGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCAGTGCTGGAAGTATTCAGC
IgHJ2IgHJ2 GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGAGAGATCGAAGTACCAGTAGGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGAGAGATCGAAGTACCAGTAG
IgHJ3IgHJ3 GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCCCCAGATATCAAAAGCATCGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCCCCAGATATCAAAAGCATC
IgHJ4IgHJ4 GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGGCCCCAGTAGTCAAAGTAGGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGGCCCCAGTAGTCAAAGTAG
IgHJ5IgHJ5 GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCCCAGGGGTCGAACCAGTTGGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCCCAGGGGTCGAACCAGTTG
IgHJ6IgHJ6 GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCCCAGACGTCCATGTAGTAGGTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCCCAGACGTCCATGTAGTAG
二、第一次PCR:Second, the first PCR:
1、多重PCR体系配制(TRB的J-V区):1. Multiplex PCR system preparation (J-V region of TRB):
成分ingredient 体积volume
Qiagen Multiplex PCR 2xMMQiagen Multiplex PCR 2xMM 25μl25μl
TRBV工作引物TRBV working primer 5μl5μl
TRBJ工作引物TRBJ working primers 2.52.5
100ng DNA+ddH 2O 100ng DNA + ddH 2 O 17.5μl17.5 μl
TotalTotal 50μl50μl
多重PCR体系配制(Igh的J-V区):Multiplex PCR system preparation (Igh's J-V region):
成分ingredient 体积volume
Qiagen Multiplex PCR 2xMMQiagen Multiplex PCR 2xMM 25μl25μl
IghV工作引物IghV working primer 5μl5μl
IghJ工作引物IghJ working primer 2.52.5
100ng DNA+ddH 2O 100ng DNA + ddH 2 O 17.5μl17.5 μl
TotalTotal 50μl50μl
2、多重PCR程序:2. Multiplex PCR program:
Figure PCTCN2018088989-appb-000014
Figure PCTCN2018088989-appb-000014
3、第一次磁珠纯化与size selection:3. The first magnetic bead purification and size selection:
3.1、前置作业:AMPure XP使用前回温到室温,分装到离心管使用;体积浓度为80%酒精需新鲜配制;Purify使用1.5ml离心管或是200μl以上的96孔盘。3.1. Pre-operation: AMPure XP is warmed to room temperature before use, and aliquoted into a centrifuge tube; 80% alcohol by volume must be freshly prepared; Purify uses a 1.5ml centrifuge tube or a 96-well plate with 200μl or more.
3.2、以体积0.9:1的方式混合AMPure XP Beads和步骤2的多重PCR产物(36μl AMPure Beads+40μl多重PCR产物),吹打至少10次,使其充分混合。3.2. Mix AMPure XP Beads and the multiplex PCR product from step 2 (36 μl AMPure Beads + 40 μl multiplex PCR product) in a volume of 0.9: 1, and mix by pipetting at least 10 times.
3.3、室温下孵育10mins。3.3 Incubate at room temperature for 10mins.
3.4、将离心管放到磁座上2mins或等到液体澄清。3.4 Place the centrifuge tube on the magnetic stand for 2mins or wait until the liquid is clear.
3.5、将70μl上清液移到新的离心管,不要将上清液丢弃。3.5. Transfer 70 μl of the supernatant to a new centrifuge tube. Do not discard the supernatant.
3.6、以体积1:1的方式混合AMPure XP Beads和前一步骤所取得的上 清液(70μl AMPure Beads+70μl上清液),吹打至少10次,使其充分混合。3.6. Mix AMPure XP Beads and the supernatant obtained in the previous step (70 μl AMPure Beads + 70 μl supernatant) in a volume of 1: 1, and pipette at least 10 times to mix thoroughly.
3.7、室温下孵育10mins。3.7 Incubate at room temperature for 10mins.
3.8、将离心管放到磁座上2mins或等到液体澄清。3.8 Place the centrifuge tube on the magnetic stand for 2mins or wait until the liquid is clear.
3.9、吸去上清液并丢弃,小心不要吸到磁珠。可将吸液量调整到比总体积少5μl去吸。3.9 Aspirate the supernatant and discard. Be careful not to suck the magnetic beads. The amount of aspiration can be adjusted to 5 μl less than the total volume for aspiration.
3.10、保持离心管在磁座上,加入200μl体积浓度为80%乙醇,室温孵育30secs,将所有的上清液吸除并丢弃。3.10. Keep the centrifuge tube on the magnetic base, add 200 μl of 80% ethanol in volume concentration, and incubate at room temperature for 30secs. Aspirate and discard all the supernatant.
3.11、重复步骤3.10一次(总共有两次的体积浓度为80%乙醇洗涤)。3.11. Repeat step 3.10 once (there are two washings with a volume concentration of 80% ethanol).
3.12、以较细的吸管将残余的溶液吸除干净。3.12. Remove the residual solution with a thin pipette.
3.13、空气干燥离心管10mins。3.13. Air dry the centrifuge tube for 10mins.
3.14、将离心管拿离磁座,加入17.5μl Resuspension buffer,吹打至少10次,使其充分混合。3.14. Remove the centrifuge tube from the magnetic base, add 17.5 μl Resuspension buffer, and blow at least 10 times to mix thoroughly.
3.15、室温下孵育2mins。3.15. Incubate at room temperature for 2mins.
3.16、将离心管放到磁座上2mins或等到液体澄清。3.16. Place the centrifuge tube on the magnetic stand for 2mins or wait until the liquid is clear.
3.17、将15μl上清液吸到新的PCR管保存。3.17. Aspirate 15 μl of the supernatant into a new PCR tube for storage.
三、第二次PCR:Third, the second PCR:
1、建库PCR体系配制:1. Preparation of library PCR system:
成分ingredient 体积volume
Phusion 2×MMPhusion 2 × MM 25μl25μl
测序引物1Sequencing Primer 1 5μl 5μl
测序引物3Sequencing Primer 3 5μl5μl
100ng First elution DNA+ddH2O100ng First elution DNA + ddH2O 15μl15μl
TotalTotal 50μl50μl
其中,测序引物1包括特异性识别第一接头的核苷酸序列(SEQ ID NO:86)和测序用接头A;测序引物3包括特异性识别GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAG的核苷酸序列和测序用接头B,测序用接头A和测序用接头B为illumina测序仪专用引物。Among them, sequencing primer 1 includes a nucleotide sequence that specifically recognizes the first linker (SEQ ID NO: 86) and sequencing linker A; sequencing primer 3 includes a nucleotide sequence that specifically recognizes GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAG and sequencing linker B, sequencing The adaptor A and the adaptor B for sequencing are primers for the illumina sequencer.
2、建库PCR程序:2. Library PCR program:
Figure PCTCN2018088989-appb-000015
Figure PCTCN2018088989-appb-000015
Figure PCTCN2018088989-appb-000016
Figure PCTCN2018088989-appb-000016
3、第二次磁珠纯化:3. The second magnetic bead purification:
3.1、前置作业:AMPure XP使用前回温到室温,分装到离心管使用;体积浓度为80%酒精需新鲜配制;Purify使用1.5ml离心管或是200μl以上的96孔盘。3.1. Pre-operation: AMPure XP is warmed to room temperature before use, and aliquoted into a centrifuge tube; 80% alcohol by volume must be freshly prepared; Purify uses a 1.5ml centrifuge tube or a 96-well plate with 200μl or more.
3.2、以体积1:1的方式混合AMPure XP Beads和第二次PCR产物(50μl AMPure Beads+50μl第二次PCR产物),吹打至少10次,使其充分混合。3.2. Mix AMPure XPBeads and the second PCR product (50μl AMPureBeads + 50μl second PCR product) in a volume of 1: 1, and blow at least 10 times to mix thoroughly.
3.3、室温下孵育10mins。3.3 Incubate at room temperature for 10mins.
3.4、将离心管放到磁座上2mins或等到液体澄清。3.4 Place the centrifuge tube on the magnetic stand for 2mins or wait until the liquid is clear.
3.5、吸去上清液并丢弃,小心不要吸到磁珠。可将吸液量调整到比总体积少5μl去吸取。3.5. Aspirate the supernatant and discard. Be careful not to suck the magnetic beads. The amount of pipette can be adjusted to 5μl less than the total volume for pipetting.
3.6、保持离心管在磁座上,加入200μl体积浓度为80%乙醇,室温孵育30secs,将所有的上清液吸除并丢弃。3.6. Keep the centrifuge tube on the magnetic base, add 200 μl of 80% ethanol in volume concentration, and incubate at room temperature for 30 secs. Aspirate and discard all the supernatant.
3.7、重复步骤3.6一次(总共有两次的体积浓度为80%乙醇洗涤)3.7 Repeat step 3.6 once (there are two washings with a volume concentration of 80% ethanol)
3.8、以较细的吸管将残余的溶液吸除干净。3.8. Absorb the remaining solution with a thin pipette.
3.9、室温干燥离心管10mins。3.9. Dry the centrifuge tube at room temperature for 10mins.
3.10、将离心管拿离磁座,加入22.5μl Resuspension buffer,吹打至少10次,使其充分混合。3.10. Remove the centrifuge tube from the magnetic base, add 22.5 μl Resuspension buffer, and blow at least 10 times to mix thoroughly.
3.11、室温下孵育2mins。3.11 Incubate at room temperature for 2mins.
3.12、将离心管放到磁座上2mins或等到液体澄清。3.12 Place the centrifuge tube on the magnetic stand for 2mins or wait until the liquid is clear.
3.13、将20μl上清液吸到新的离心管保存。3.13. Aspirate 20 μl of the supernatant into a new centrifuge tube for storage.
根据上述的实验流程,在同一个体中进行3次采样,每一样本提取的DNA分成两份,一份用于实施例1方案的文库构建(TRB建库和Igh建库),另外一份用于对比例方案的文库,进行测序,分析,经过筛选,通过质量要求的reads进入比较分析,3次采样的数据进行分析。请参阅图2, 进行测序时会对可变区文库进行多次PCR,从而引入不同的PCR错误,相对于对比例,实施例1在可变区文库中添加校对随机段,有利于在测序分析时校正PCR错误,将确保后续的测序结果可以通过校对随机段进行较偏,极大提高可变区文库测序的准确性,随机选取2M的reads进行独特克隆数分析。三次结果求平均数以及其变异系数。通过图3可以看到,图3横坐标的左边的2M测序Reads为对比例建库后进行的TCR克隆数的数据,右边的2M测序Reads+random barcode为实施例1TRB V-J区建库的TCR克隆数的数据,从图3可知的变异系数可知,对比例的TCR克隆数的变异系数为24.8%,实施例1的TCR克隆数的变异系数为3.9%,说明采用实施例1的方案产生的结果比较稳定,对比例的TCR克隆数均值为46906条独特的克隆,实施例1的TCR克隆数均值为65741条独特的克隆,说明实施例1产生的独特克隆更加丰度。而采用对比例的方案产生的结果波动比较大,同时产生的独特克隆相对更少一点。According to the above experimental procedure, three samples were taken in the same individual, and the DNA extracted from each sample was divided into two parts, one for the library construction (TRB and Igh) for the protocol of Example 1, and the other for For the library of the comparative scheme, sequencing, analysis, and screening were performed, and the comparative analysis was performed through the reads with quality requirements, and the data of 3 samples were analyzed. Please refer to FIG. 2. When performing sequencing, multiple PCRs are performed on the variable region library to introduce different PCR errors. Compared with the comparative example, Example 1 adds a proofreading random segment to the variable region library, which is beneficial for sequencing analysis. Correcting PCR errors at time will ensure that subsequent sequencing results can be biased by proofreading random segments, greatly improving the accuracy of variable region library sequencing, and randomly selecting 2M reads for unique clone number analysis. The three results were averaged and the coefficient of variation. It can be seen from FIG. 3 that the 2M sequencing Reads on the left side of the abscissa of FIG. 3 is the data of the number of TCR clones performed after the comparative library is built, and the 2M sequencing Reads + random barcode on the right side is the TCR clone of the library built in the TRB VJ area of Example 1 The coefficient of variation of the number of data is shown in FIG. 3. The coefficient of variation of the number of TCR clones in the comparative example is 24.8%, and the coefficient of variation of the number of TCR clones in Example 1 is 3.9%, which illustrates the results produced by the scheme of Example 1. It is relatively stable. The average number of TCR clones in the comparative example is 46,906 unique clones, and the average number of TCR clones in Example 1 is 65,741 unique clones, indicating that the unique clones generated in Example 1 are more abundant. However, the results produced by the comparative example scheme fluctuated greatly, and the number of unique clones produced at the same time was relatively small.
通过图4可以看到,图4横坐标的左边的2M测序Reads为对比例建库后进行的BCR克隆数的数据,右边的2M测序Reads+random barcode为实施例1IgH V-J区建库的BCR克隆数的数据,从图4变异系数可知,对比例的BCR克隆数的变异系数为32.7%,实施例1的BCR克隆数的变异系数为3.7%,说明采用实施例1的方案产生的结果比较稳定,对比例的BCR克隆数均值为55861条独特的克隆,实施例1的BCR克隆数为76370条独特的克隆,说明实施例1产生的独特克隆更加丰度。而采用对比例的方案产生的结果波动比较大,同时产生的独特克隆相对更少一点It can be seen from FIG. 4 that the 2M sequencing Reads on the left side of the abscissa of FIG. 4 is the data of the number of BCR clones performed after the comparative library is built, and the 2M sequencing Reads + random barcode on the right is the BCR clone of the library built in the IgH VJ area of Example 1. From the coefficient of variation shown in Figure 4, the coefficient of variation of the number of BCR clones in the comparative example is 32.7%, and the coefficient of variation of the number of BCR clones in Example 1 is 3.7%, indicating that the results produced by the solution of Example 1 are relatively stable. The average number of BCR clones in the comparative example is 55,861 unique clones, and the number of BCR clones in Example 1 is 76,370 unique clones, indicating that the unique clones generated in Example 1 are more abundant. However, the results produced by the comparative example scheme have relatively large fluctuations and relatively few unique clones.
以上所述仅是本发明的优选实施方式,应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明原理的前提下,还可以做出若干改进和润饰,这些改进和润饰也应视为本发明的保护范围。The above is only a preferred embodiment of the present invention. It should be noted that, for those of ordinary skill in the art, without departing from the principle of the present invention, a number of improvements and retouches can be made. These improvements and retouches also It should be regarded as the protection scope of the present invention.
Figure PCTCN2018088989-appb-000017
Figure PCTCN2018088989-appb-000017
Figure PCTCN2018088989-appb-000018
Figure PCTCN2018088989-appb-000018
Figure PCTCN2018088989-appb-000019
Figure PCTCN2018088989-appb-000019
Figure PCTCN2018088989-appb-000020
Figure PCTCN2018088989-appb-000020
Figure PCTCN2018088989-appb-000021
Figure PCTCN2018088989-appb-000021
Figure PCTCN2018088989-appb-000022
Figure PCTCN2018088989-appb-000022
Figure PCTCN2018088989-appb-000023
Figure PCTCN2018088989-appb-000023
Figure PCTCN2018088989-appb-000024
Figure PCTCN2018088989-appb-000024
Figure PCTCN2018088989-appb-000025
Figure PCTCN2018088989-appb-000025
Figure PCTCN2018088989-appb-000026
Figure PCTCN2018088989-appb-000026
Figure PCTCN2018088989-appb-000027
Figure PCTCN2018088989-appb-000027
Figure PCTCN2018088989-appb-000028
Figure PCTCN2018088989-appb-000028
Figure PCTCN2018088989-appb-000029
Figure PCTCN2018088989-appb-000029
Figure PCTCN2018088989-appb-000030
Figure PCTCN2018088989-appb-000030
Figure PCTCN2018088989-appb-000031
Figure PCTCN2018088989-appb-000031
Figure PCTCN2018088989-appb-000032
Figure PCTCN2018088989-appb-000032
Figure PCTCN2018088989-appb-000033
Figure PCTCN2018088989-appb-000033
Figure PCTCN2018088989-appb-000034
Figure PCTCN2018088989-appb-000034
Figure PCTCN2018088989-appb-000035
Figure PCTCN2018088989-appb-000035
Figure PCTCN2018088989-appb-000036
Figure PCTCN2018088989-appb-000036
Figure PCTCN2018088989-appb-000037
Figure PCTCN2018088989-appb-000037
Figure PCTCN2018088989-appb-000038
Figure PCTCN2018088989-appb-000038
Figure PCTCN2018088989-appb-000039
Figure PCTCN2018088989-appb-000039
Figure PCTCN2018088989-appb-000040
Figure PCTCN2018088989-appb-000040
Figure PCTCN2018088989-appb-000041
Figure PCTCN2018088989-appb-000041
Figure PCTCN2018088989-appb-000042
Figure PCTCN2018088989-appb-000042
Figure PCTCN2018088989-appb-000043
Figure PCTCN2018088989-appb-000043
Figure PCTCN2018088989-appb-000044
Figure PCTCN2018088989-appb-000044
Figure PCTCN2018088989-appb-000045
Figure PCTCN2018088989-appb-000045
Figure PCTCN2018088989-appb-000046
Figure PCTCN2018088989-appb-000046
Figure PCTCN2018088989-appb-000047
Figure PCTCN2018088989-appb-000047

Claims (21)

  1. 一种可变区序列文库的构建方法,其特征在于,包括以下步骤:A method for constructing a variable region sequence library includes the following steps:
    步骤一、获得含有编码可变区的DNA样本;Step 1: Obtain a DNA sample containing a variable region;
    步骤二、以所述DNA样本作为模板,通过第一引物群延伸编码所述可变区的DNA序列,获得第一扩增产物库,其中,所述第一引物群包括特异性识别J区的所有亚型的编码序列的的第一引物,所述第一引物包括特异性识别J区的编码序列的核苷酸序列、校对随机段和第一接头,且所述特异性识别J区的编码序列的核苷酸序列、所述校对随机段和所述第一接头依次连接,所述第一引物群的校对随机段的序列互不相同;Step 2: Use the DNA sample as a template to extend a DNA sequence encoding the variable region through a first primer group to obtain a first amplification product library, wherein the first primer group includes a specific recognition region for the J region. First primers of all subtype coding sequences, the first primers include a nucleotide sequence that specifically recognizes the coding sequence of the J region, a proofreading random segment, and a first linker, and the code that specifically recognizes the J region The nucleotide sequence of the sequence, the proofreading random segment and the first linker are sequentially connected, and the sequences of the proofreading random segment of the first primer group are different from each other;
    步骤三、以所述第一扩增产物库作为模板,通过第二引物群和第一接头的引物扩增编码所述可变区的DNA序列,获得可变区序列组合产物,其中,所述第二引物群包括特异性识别V区的所有亚型的编码序列的的第二引物;所述第二引物包括特异性识别V区的编码序列的核苷酸序列和第二接头,且所述特异性识别V区的编码序列的核苷酸序列和所述第二接头相互连接;所述第一接头的引物包括特异性识别第一接头的核苷酸序列。Step 3: Using the first amplification product library as a template, a DNA sequence encoding the variable region is amplified by primers of a second primer group and a first adapter to obtain a variable region sequence combination product, wherein the The second primer group includes a second primer that specifically recognizes coding sequences of all subtypes of the V region; the second primer includes a nucleotide sequence and a second linker that specifically recognizes coding sequences of the V region, and the The nucleotide sequence that specifically recognizes the coding sequence of the V region and the second linker are connected to each other; the primers of the first linker include a nucleotide sequence that specifically recognizes the first linker.
  2. 根据权利要求1所述的可变区序列文库的构建方法,其特征在于,还包括步骤四,步骤四具体包括:以所述可变区序列组合产物为模板,通过第一测序接头和第二测序接头扩增编码所述可变区的DNA序列,获得可变区序列文库,其中,所述第一测序接头包括特异性识别所述第一接头的核苷酸序列和测序用接头A;所述第二测序接头包括特异性识别所述第二接头的核苷酸序列和测序用接头B。The method for constructing a variable region sequence library according to claim 1, further comprising step four, which specifically comprises: using the combination product of the variable region sequence as a template, passing a first sequencing adapter and a second A sequencing adapter amplifies a DNA sequence encoding the variable region to obtain a variable region sequence library, wherein the first sequencing adapter includes a nucleotide sequence that specifically recognizes the first adapter and a sequencing adapter A; The second sequencing linker includes a nucleotide sequence that specifically recognizes the second linker and a linker B for sequencing.
  3. 根据权利要求1或2所述的可变区序列文库的构建方法,其特征在于,所述校对随机段的序列长度为8-20个核苷酸。The method for constructing a variable region sequence library according to claim 1 or 2, wherein the sequence length of the proofreading random segment is 8-20 nucleotides.
  4. 根据权利要求1至3任意一项所述的可变区序列文库的构建方法,其特征在于,所述校对随机段的序列长度为8-10个核苷酸。The method for constructing a variable region sequence library according to any one of claims 1 to 3, wherein the sequence length of the proofreading random segment is 8-10 nucleotides.
  5. 根据权利要求1至4任意一项所述的可变区序列文库的构建方法,其特征在于,多条所述第一接头的序列互相相同。The method for constructing a variable region sequence library according to any one of claims 1 to 4, wherein the sequences of a plurality of the first linkers are identical to each other.
  6. 根据权利要求1至5任意一项所述的可变区序列文库的构建方法,其特征在于,所述延伸具体包括:变性98℃,40s;延伸60℃,2min;终延伸72℃,2min;1个循环。The method for constructing a variable region sequence library according to any one of claims 1 to 5, wherein the extension specifically comprises: denaturation 98 ° C, 40s; extension 60 ° C, 2min; final extension 72 ° C, 2min; 1 cycle.
  7. 根据权利要求1至6任意一项所述的可变区序列文库的构建方法,其特征在于,所述步骤三的扩增为多重PCR。The method for constructing a variable region sequence library according to any one of claims 1 to 6, wherein the amplification in step 3 is multiplex PCR.
  8. 根据权利要求7所述的可变区序列文库的构建方法,其特征在于,所述多重PCR具体包括:预变性95℃,15s;变性94℃,40s;退火60℃,4min;延伸72℃,90s;终延伸72℃,10s;35个循环。The method for constructing a variable region sequence library according to claim 7, wherein the multiplex PCR specifically comprises: pre-denaturation 95 ° C, 15s; denaturation 94 ° C, 40s; annealing 60 ° C, 4min; extension 72 ° C, 90s; final extension 72 ° C, 10s; 35 cycles.
  9. 根据权利要求1至8任意一项所述的可变区序列文库的构建方法,其特征在于,所述可变区序列为B细胞受体或T细胞受体的可变区序列。The method for constructing a variable region sequence library according to any one of claims 1 to 8, wherein the variable region sequence is a variable region sequence of a B cell receptor or a T cell receptor.
  10. 根据权利要求1至9任意一项所述的可变区序列文库的构建方法,其特征在于,所述含有编码可变区的DNA样本为从动物外周血中提取的全基因组DNA。The method for constructing a variable region sequence library according to any one of claims 1 to 9, wherein the DNA sample containing the variable region encoding is a whole genomic DNA extracted from animal peripheral blood.
  11. 根据权利要求1至10任意一项所述的可变区序列文库的构建方法,其特征在于所述第一引物群的校对随机段的序列相互间不产生引物二聚体。The method for constructing a variable region sequence library according to any one of claims 1 to 10, wherein the sequences of the proofreading random segments of the first primer group do not generate primer dimers with each other.
  12. 一种构建可变区序列文库的试剂盒,其特征在于,包括以下引物:第一引物群、第一接头的引物和第二引物群;A kit for constructing a variable region sequence library, comprising the following primers: a first primer group, a primer for a first linker, and a second primer group;
    其中,所述第一引物群包括特异性识别J区的所有亚型的编码序列的的第一引物;Wherein, the first primer group includes first primers that specifically recognize coding sequences of all subtypes of the J region;
    所述第一引物包括特异性识别J区的编码序列的核苷酸序列、校对随机段和第一接头,且所述特异性识别J区的编码序列的核苷酸序列、所述校对随机段和所述第一接头依次连接,所述第一引物群的校对随机段的序列互不相同;The first primer includes a nucleotide sequence that specifically recognizes the coding sequence of the J region, a proofreading random segment, and a first linker, and the nucleotide sequence that specifically recognizes the coding sequence of the J region, and the proofreading random segment. Connected to the first link in sequence, and the sequences of the proofreading random segments of the first primer group are different from each other;
    所述第二引物群包括特异性识别V区的所有亚型的编码序列的的第二引物;The second primer group includes second primers that specifically recognize coding sequences of all subtypes of the V region;
    所述第二引物包括特异性识别V区的编码序列的核苷酸序列和第二接 头,且所述特异性识别V区的编码序列的核苷酸序列和所述第二接头相互连接;The second primer includes a nucleotide sequence that specifically recognizes the coding sequence of the V region and a second adapter, and the nucleotide sequence that specifically recognizes the coding sequence of the V region and the second linker are connected to each other;
    所述第一接头的引物包括特异性识别第一接头的核苷酸序列。The primer of the first linker includes a nucleotide sequence that specifically recognizes the first linker.
  13. 根据权利要求12所述的构建可变区序列文库的试剂盒,其特征在于,编码可变区的DNA样本为T细胞受体的序列,所述第一引物群包括SEQ ID NO:1-13所示核苷酸序列。The kit for constructing a variable region sequence library according to claim 12, wherein the DNA sample encoding the variable region is a sequence of a T cell receptor, and the first primer group includes SEQ ID NO: 1-13 Nucleotide sequence shown.
  14. 根据权利要求12或13所述的构建可变区序列文库的试剂盒,其特征在于,编码可变区的DNA样本为T细胞受体的序列,所述第二引物群包括SEQ ID NO:14-65所示核苷酸序列。The kit for constructing a variable region sequence library according to claim 12 or 13, wherein the DNA sample encoding the variable region is a sequence of a T cell receptor, and the second primer group includes SEQ ID NO: 14 The nucleotide sequence shown at -65.
  15. 根据权利要求12至14任意一项所述的构建可变区序列文库的试剂盒,其特征在于,编码可变区的DNA样本为B细胞受体的序列,所述第一引物群包括SEQ ID NO:66-71所示核苷酸序列。The kit for constructing a variable region sequence library according to any one of claims 12 to 14, wherein the DNA sample encoding the variable region is a sequence of a B cell receptor, and the first primer group includes SEQ ID NO: 66-71 nucleotide sequence.
  16. 根据权利要求12至15任意一项所述的构建可变区序列文库的试剂盒,其特征在于,编码可变区的DNA样本为B细胞受体的序列,所述第二引物群包括SEQ ID NO:72-85所示核苷酸序列。The kit for constructing a variable region sequence library according to any one of claims 12 to 15, wherein the DNA sample encoding the variable region is a sequence of a B cell receptor, and the second primer group includes SEQ ID NO: 72-85 nucleotide sequence.
  17. 根据权利要求12至16任意一项所述的构建可变区序列文库的试剂盒,其特征在于,所述第一接头为SEQ ID NO:86所示核苷酸序列。The kit for constructing a variable region sequence library according to any one of claims 12 to 16, wherein the first linker is a nucleotide sequence represented by SEQ ID NO: 86.
  18. 根据权利要求12至17任意一项所述的构建可变区序列文库的试剂盒,其特征在于,所述第二接头为SEQ ID NO:87所示核苷酸序列。The kit for constructing a variable region sequence library according to any one of claims 12 to 17, wherein the second linker is a nucleotide sequence represented by SEQ ID NO: 87.
  19. 根据权利要求12至18任意一项所述的构建可变区序列文库的试剂盒,其特征在于,还包括第一测序接头和第二测序接头;The kit for constructing a variable region sequence library according to any one of claims 12 to 18, further comprising a first sequencing adapter and a second sequencing adapter;
    其中,所述第一测序接头包括特异性识别所述第一接头的核苷酸序列和测序用接头A;所述第二测序接头包括特异性识别所述第二接头的核苷酸序列和测序用接头B。Wherein, the first sequencing adapter includes a nucleotide sequence that specifically recognizes the first adapter and sequencing adapter A; the second sequencing adapter includes a nucleotide sequence that specifically recognizes the second adapter and sequencing Use connector B.
  20. 根据权利要求19所述的构建可变区序列文库的试剂盒,其特征在于,所述测序用接头A和所述测序用接头B为二代测序仪或三代测序仪的专用引物。The kit for constructing a variable region sequence library according to claim 19, wherein the sequencing adapter A and the sequencing adapter B are special primers of a second-generation sequencer or a third-generation sequencer.
  21. 一种可变区序列的测序方法,其特征在于,包括如根据权利要求1至11任一项所述的方法或如权利要求12至20任意一项所述的构建可变区序列文库的试剂盒,构建得到可变区序列文库;A method for sequencing a variable region sequence, comprising the method according to any one of claims 1 to 11 or the reagent for constructing a variable region sequence library according to any one of claims 12 to 20 Cassette to construct a variable region sequence library;
    以及,对所述可变区测序文库进行高通量测序,得到可变区序列。And, performing high-throughput sequencing on the variable region sequencing library to obtain a variable region sequence.
PCT/CN2018/088989 2018-05-30 2018-05-30 Method for constructing variable region sequence library, sequencing method, and kit thereof WO2019227331A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/CN2018/088989 WO2019227331A1 (en) 2018-05-30 2018-05-30 Method for constructing variable region sequence library, sequencing method, and kit thereof
CN201880000622.0A CN109415768B (en) 2018-05-30 2018-05-30 Variable region sequence library construction method, sequencing method and kit thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2018/088989 WO2019227331A1 (en) 2018-05-30 2018-05-30 Method for constructing variable region sequence library, sequencing method, and kit thereof

Publications (1)

Publication Number Publication Date
WO2019227331A1 true WO2019227331A1 (en) 2019-12-05

Family

ID=65462085

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2018/088989 WO2019227331A1 (en) 2018-05-30 2018-05-30 Method for constructing variable region sequence library, sequencing method, and kit thereof

Country Status (2)

Country Link
CN (1) CN109415768B (en)
WO (1) WO2019227331A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113122618A (en) * 2021-03-09 2021-07-16 武汉弘康医学检验实验室股份有限公司 Method for accurately detecting T cell immune repertoire based on high-throughput sequencing and primer system thereof

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108707653B (en) * 2018-05-30 2021-11-09 广州合谐医疗科技有限公司 Kit for constructing variable region sequence library and sequencing method of variable region sequence
CN110257476A (en) * 2019-05-31 2019-09-20 南方医科大学南方医院 A kind of construction method of immune group library high-throughput sequencing library that screening sample room cross reaction

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005084134A2 (en) * 2004-03-04 2005-09-15 Dena Leshkowitz Quantifying and profiling antibody and t cell receptor gene expression
CN105506746A (en) * 2014-09-22 2016-04-20 深圳华大基因科技有限公司 Method for constructing variable region sequencing library, and method for determining variable region nucleic acid sequence
CN107893068A (en) * 2017-10-20 2018-04-10 重庆天科雅生物科技有限公司 A kind of method for building people TCRbetaCDR3 areas library

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108707653B (en) * 2018-05-30 2021-11-09 广州合谐医疗科技有限公司 Kit for constructing variable region sequence library and sequencing method of variable region sequence

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005084134A2 (en) * 2004-03-04 2005-09-15 Dena Leshkowitz Quantifying and profiling antibody and t cell receptor gene expression
CN105506746A (en) * 2014-09-22 2016-04-20 深圳华大基因科技有限公司 Method for constructing variable region sequencing library, and method for determining variable region nucleic acid sequence
CN107893068A (en) * 2017-10-20 2018-04-10 重庆天科雅生物科技有限公司 A kind of method for building people TCRbetaCDR3 areas library

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DMITRY A. BOLOTIN: "Next generation sequencing for TCR repertoire profi- ling: Platform-specific features and correction algorithms", EUR. J. IMMUNOL., 24 September 2012 (2012-09-24), XP055235351 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113122618A (en) * 2021-03-09 2021-07-16 武汉弘康医学检验实验室股份有限公司 Method for accurately detecting T cell immune repertoire based on high-throughput sequencing and primer system thereof

Also Published As

Publication number Publication date
CN109415768A (en) 2019-03-01
CN109415768B (en) 2021-11-16

Similar Documents

Publication Publication Date Title
CN105442054B (en) The method that storehouse is built in the amplification of multiple target site is carried out to plasma DNA
WO2017136059A1 (en) Using cell-free dna fragment size to determine copy number variations
WO2019227331A1 (en) Method for constructing variable region sequence library, sequencing method, and kit thereof
CN106086162A (en) A kind of double label joint sequences for detecting Tumor mutations and detection method
WO2017028753A1 (en) Multiplex pcr primer and application thereof
JP2014521334A (en) How to determine the presence or absence of different aneuploidies in a sample
KR20130038353A (en) New pcr sequencing method and use thereof in hla genotyping
WO2016049993A1 (en) Method and system for testing identity relations among multiple biological samples
CN108517567B (en) Adaptor, primer group, kit and library construction method for cfDNA library construction
WO2018133546A1 (en) CONSTRUCTION METHOD, DETECTION METHOD AND KIT FOR NON-INVASIVE PRENATAL FETAL α-THALASSEMIA GENE MUTATION DETECTION LIBRARY
CN107779495B (en) Construction method and kit of T cell antigen receptor diversity sequencing library
WO2021052310A1 (en) Dna library construction method
CN101921841A (en) HLA (Human Leukocyte Antigen) gene high-resolution genotyping method based on Illumina GA sequencing technology
WO2023098492A1 (en) Sequencing library construction method and application
CN109486912A (en) A kind of probe primer combination and design method for digital pcr amplification
WO2018133547A1 (en) METHOD FOR CONSTRUCTING LIBRARY FOR NON-INVASIVE PRENATAL FETAL β-THALASSEMIA GENE MUTATION DETECTION, DETECTION METHOD AND KIT
Wang et al. Optimization and evaluation of viral metagenomic amplification and sequencing procedures toward a genome-level resolution of the human fecal DNA virome
CN108707653B (en) Kit for constructing variable region sequence library and sequencing method of variable region sequence
CN109280696B (en) Method for splitting mixed sample by SNP detection technology
CN109295050A (en) Both-end label specific linkers, kit and the banking process in the library Blood Trace cfDNA
TW201321520A (en) Method and system for virus detection
WO2019014936A1 (en) Targeted enrichment method and kit for detecting low-frequency mutation
WO2016119448A2 (en) Artificial exogenous reference molecule for comparing types and natural abundance between microorganisms of different species and genera
CN105087560A (en) Multiplex PCR primers and method based on high-throughput sequencing to build pig BCR heavy chain library
CN111005075A (en) Y-shaped joint for double-sample co-construction sequencing library and method for double-sample co-construction sequencing library

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18920854

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18920854

Country of ref document: EP

Kind code of ref document: A1